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Abstract 
Background: Populations of African ancestry have greater bone strength and lower osteoporotic 
fracture risk than other ethnic groups but there is little information about skeletal health among 
individuals of African heritage. 
 
Methods: Univariate, bivariate and multivariate analytical methods under the variance 
components framework were employed to dissect the genetic and environment determinants for 
DXA and pQCT measured bone strength related phenotypes. Our analyses were performed on 
phenotypic and genotypic data on 471 individuals aged 18+ from 8 large, multigenerational 
Afro-Caribbean families. 
 
Results: The major conclusions of this study are that (1) compared to Caucasians and African 
Americans, Afro-Caribbeans have the highest peak areal BMD and slowest bone loss rate, but 
heritabilities of many bone strength related traits are similar among different populations, and (2) 
genes and environmental factors differentially affect trabecular versus cortical traits, and also 
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BMD versus bone size. These conclusions are supported by differences in heritability and 
genetic correlation estimates among these bone categories, differential effects of environmental 
risk factors, as well as associations with different candidate genes.  We also evaluated the 
capability of two multivariate analysis methods for uncovering underlying genetic factors using 
both simulated and real family data. We concluded Factor Analysis behaves better for both 
simulated and real data compare to Principal Component Analysis. The residual strategy 
increases the probability that composite phenotypes detect underlying genetic components if no 
gene-environment interaction is involved. And most importantly, composite phenotypes from 
multivariate analysis demonstrated their capabilities to capture more and stronger association 
signals in real data analysis.  
 
Public health significance: Our work has identified the facts that environmental risk factors and 
genetic determinants may differentially affect various bone compartments and types of bone 
phenotypes. This information will contribute to the understanding of the underlying genetic 
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1.0  INTRODUCTION 
1.1 OSTEOPOROSIS 
Osteoporosis is a systemic skeletal disease characterized by low bone mass and the 
microarchitectural deterioration of bone tissue with a consequent increase in bone fragility and 
susceptibility to fractures. (Consensus 1993) (3) The pathogenesis of fragility fracture almost 
always involves trauma and is not necessarily associated with reduced bone mass. Thus, fragility 
fracture should neither be used synonymously nor interchangeably as a phenotype for 
osteoporosis (2). 
Osteoporosis affects the elderly, both sexes, and all racial groups. Although most 
American women under the age of 50 have normal bone marrow density (BMD), 27% are 
osteopenic (Osteopenia is low bone density. If not treated, it may result in osteoporosis.) 70% are 
osteoporotic at the hip, lumbar spine, or forearm by the age of 80 years. Epidemiologic studies 
from North America have estimated the remaining lifetime risk of common fragility fractures 
among white women aged 50 years to be 17.5% for hip fracture, 15.6% for clinically diagnosed 
vertebral fracture, and 16% for distal forearm fracture. The corresponding risks among men are 
6%, 5%, and 2.5%, respectively. A British study using the General Practice Research Database 
estimated the lifetime risk of any fracture to be 53.2% at age 50 years among women and 20.7% 
at the same age among men (Table 1). 
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Several studies have suggested a wide geographic variation in hip fractures between as 
well as within countries. In general, people who live in latitudes farther from the equator seem to 
have a higher incidence of fracture (24). The highest rates of hip fracture are seen in Caucasians 
living in northern Europe, especially in Scandinavian countries, where the age-adjusted 1-year 
cumulative incidence was 903/100,000 for women and 384/100,000 for men in Norway, 1989. 
The rates are intermediate in the populations of Asia, China, and Kuwait and lowest in black 
populations (23). An Australian study concluded that although the increase in hip fracture rates 
during most of the past century may have ended, the number of admissions for hip fracture is still 
rising because of an aging population (25). Many of the lower incidence rates in the developing 
countries can be partially explained by lower life expectancy; in Latin America only 5.7% of the 
population is over 65 (26). Reduced longevity was also the explanation given for the low fracture 
rates observed in Morocco. Other papers have highlighted the poor appreciation of the role 
played by osteoporosis in fragility fracture; in one Lebanese study, fewer than 10% of hip 
fracture patients received any therapy for osteoporosis (27). 
There also exists a striking health impact of osteoporotic fracture on mortality. All 
osteoporotic fractures are associated with significant morbidity, but both hip and vertebral 
fractures are also associated with excess mortality. Although this may represent complications of 
the fracture and subsequent surgery for hip fractures, it is likely to reflect comorbidity in persons 
experiencing vertebral fracture. By 2 years after hip fracture, mortality rates decline back to 
baseline except in elderly patients and among men. The four main predictors for higher mortality 
seem to be male sex, increasing age, coexisting illness, and poor functional status before fracture. 
The 5-year survival seems to be worse for men (72% 5-year survival) than for women (84% 5-
 2 
year survival). In women, a risk of death from cardiovascular and pulmonary disease that 
increases with increasing number of vertebral fractures has been observed (28). 
 
Table 1. Estimated Risk of Fractures at Various Ages 
 
 
1.2 ENVIRONMENTAL FACTORS RELATED TO OSTEOPOROSIS 
A detailed understanding of the environmental risk factors for osteoporosis is important for 
several reasons: first, it may help us understand the pathophysiology of the disorder; Secondly, 
they will contribute to the clinic treatment of individual patients. Thirdly, they may help in 
design of preventative strategies against the disease.  
According to one report (43), risk factors of osteoporosis can be grouped into different 
categories: those that influence the risk of falling and responses to trauma; those that influence 
the accretion and loss of BMD throughout the life course; and those that influence the skeletal 
strength independent of BMD. Table 2 summarizes the risk factors for osteoporosis and fracture 
(43). 
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In addition, race (being Caucasian or Asian), inactive lifestyle, presence of insulin-
dependent diabetes also been suggested by many reports as risk factors (1, 108).  
1.3 HERITABILITY OF OSTEOPOROSIS 
Although environmental factors play a very important role in osteoporosis, genetic influences 
appear to have a larger effect. Studies in twins and families indicate that genetic factors play an 
important role in the regulation of BMD and other determinants of osteoporotic fracture risk. The 
heritability of BMD has been estimated to lie between 50% and 85% in twin studies, with the 
strongest effects in the axial skeleton). Family-based studies have also yielded strong heritability 
estimates for BMD, with effects that are maximal in young adults and persist even after adjusting 
for lifestyle factors that are known to regulate BMD. Other determinants of osteoporotic fracture 
risk also have a heritable component, including: femoral neck geometry and hip axis length, 
ultrasound properties of bone, biochemical markers of bone turnover 8), body mass index, 
muscle strength, age at menarch and age at menopause (46). Table 3 shows the heritability 
estimation for some of the bone related traits. 
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Table 2. Risk Factors for Osteoporosis and Fracture 
 
 
Heritability of Bone Mass: Studies over the last 30 years in healthy twins consistently 
demonstrate a large genetic contribution to bone mass even into old age. A number of family 
studies using healthy parent-children pairs, healthy sister pairs, and parent-child pairs in whom 
the parent had osteoporosis have corroborated the major role of genes in determining bone mass. 
Furthermore, heritability of bone mass can be detected during childhood even though the 
skeleton is undergoing major changes in both skeletal size and mass. In addition, it was found by 
some scientists that some of the sex differences in bone mass are accounted for by gender-
specific genes (47, 48). 
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Heritability of Bone Size and Structure: Height and other anthropometric variables 
related to skeletal size have been known for many years to be highly heritable. In the early 
reports on the heritability of bone mass, variables related to bone size and structure such as 
forearm width, phalangeal cortical and medullary width were shown to be as highly heritable as 
bone mass. More recent reports examining structural variables that are important in maintaining 
bone strength at skeletal sites where osteoporotic fracture is common, highlight the strong 
heritability of bone structure at both the hip and at the spine. Hip axis length measured from 
DXA images and femur axis length measured from radiographs are both highly heritable and 
predict risk for fracture at the hip (49-51). 
 
Heritability of Bone Loss: In contrast to the extensive studies on heritability of bone 
mass, few studies on heritability of bone loss have been reported.  There are no current studies 
that powerfully address the important question of whether the rate of bone loss is heritable at 
skeletal sites where osteoporotic fracture is common (2). 
 





Heritability of Bone Turnover: Bone formation and resorption can be assessed from a 
number of biochemical markers in blood and urine. These vary with age, race, and disease and 
its treatment. Formation and resorption markers show a strong correlation among themselves. 
These markers do not measure bone mass or structure but in some circumstances may reflect 
bone gain or bone loss. In elderly white women, they may also predict hip fracture. Their 
relationship to bone strength is tenuous. Nevertheless, a number of studies have reported that 
there is a heritable component to bone turnover markers although with little consistency in the 
turnover markers across studies and little corroboration among markers within studies (52). 
Heritability of Fracture: The heritability of fracture, as expected with such a complex 
phenotype, is not strong. In a large prospective study of white American women 65 years of age 
or older, a history of hip fracture in their mother doubled the risk of hip fracture. Although there 
appears to be a genetic component to fragility fracture, it seems equally likely from these studies 
that the underlying genes may not relate to bone strength but to the risk factors for falls, which is 
also highly heritable (53). 
Heritability of Falls: The number of falls along with decreased bone strength, age, and 
previous fracture are major predictors of hip fracture. Falls are a highly complex phenotype with 
multiple environmental risk factors. Although falls also have a heritable component, the 
susceptibility genes for fracture resulting from falls are unlikely to relate to the genes underlying 
bone strength (54, 55). 
It should be noted that the residuals heritability estimates cited above may not accurately 
reflect the actual percentage of the bone traits that is due to genetic factors but, rather, may 
reflect the proportion of total variance (after removing the effect of measured covariates) in these 
traits attributable to genetic factors. Moreover, in most of the cases, the assumptions do not take 
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into account of gene–gene or gene–environment interactions and can result in artificially inflated 
estimates of a genetic contribution due to greater sharing of environmental influences. Further 
more, high heritability does not ensure large individual gene effect.  
1.4 STUDY APPROACHES FOR OSTEOPOROSIS GENES 
Statistical genetic strategies used to identify and characterize genes that are involved in the 
pathogenesis of polygenic disorders like osteoporosis include heritability estimation, genetic 
correlation calculation, linkage analysis, candidate gene studies, and experimental crosses in 
animals. Heritability estimation and genetic correlation, which dissect the genetic impact on total 
phenotypic variation, are preliminarily exploratory work before any downstream research. In 
essence, the rest of these approaches involve looking for evidence of an association between a 
phenotypic characteristic and a series of polymorphic genetic markers. The phenotypic 
characteristic may be a continuous variable such as BMD or may be a categorical variable such 
as fracture. More interestingly, we can even use “composite traits” generated by PCA (Principal 
Component Analysis). The genetic markers used in these studies are polymorphic regions of 
DNA which are analyzed by PCR-based techniques on DNA extracted from peripheral blood. 
There are two main types of marker: repeat polymorphisms of variable length (Microsatellites) 
and single nucleotide polymorphisms (SNPs). Genetic studies involve typing a large number of 
markers spread at regular intervals throughout the genome (a genome search), or typing markers 
that are concentrated in specific areas of interest (candidate loci) or specific genes of interest 
(candidate genes). Regions of chromosomes that contain alleles that influence continuous 
phenotypic traits such as BMD are termed quantitative trait loci (QTL). The power to detect a 
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QTL contributing to a multifactorial phenotype like the traits associated with osteoporosis is 
directly proportional to the magnitude of the specific effects of the QTL. The genetic tools 
commonly used for QTL identification include: whole genome linkage scans in families, sib 
pairs and experimental animals. More recently, researchers have suggested that genome-wide 
linkage disequilibrium mapping with SNPs in unrelated individuals may provide an alternative 
approach to QTL localization, although the feasibility of this remains unclear (Tenesa et.al, 
2003). Candidate gene approaches have also been widely used in the search for osteoporosis 
susceptibility genes. While candidate gene studies are in some respects more powerful than 
linkage-based approaches for the study of complex diseases, they are also prone to give false 
positive results due to population admixture, or biased selection of cases and controls. In view of 
this, associations should be regarded as provisional, pending replication in other populations or 
confirmation by techniques that use family-based controls such as the transmission 
disequilibrium test (TDT). TDT is based upon the assumption that if a given allele contributes to 
disease, then the probability that an affected person has inherited the allele from a heterozygous 
parent should vary from the expected Mendelian ratio of 50:50. Although the TDT test has been 
considered as a ‘gold standard’ for confirming the results of association studies, recent 
experience indicates that even this approach may yield results that are not reproducible (46). 
1.4.1 Genetic, Environmental and Phenotypic Correlation 
In genetic studies it is necessary to distinguish two causes of correlation between characters, 
genetic and environmental. The genetic cause of correlation is chiefly pleiotropy. Pleiotropy is 
simply the property of gene whereby it affects two or more characters, so that if the gene is 
segregating it causes simultaneous variation in the character it affects. The degree of correlation 
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arising from pleiotropy expresses the extent to which two characters are influenced by the same 
genes. But the correlation resulting from pleiotropy is the overall, or net effects of all the 
segregating genes that affect both characters. Some genes may increase both characters, while 
others increases one and reduce the other; the former tend to cause a positive correlation; the 
latter a negative one. So pleiotropy does not necessarily causes a detectable correlation. The 
environment is a cause in so far as two characters are influenced by the same differences of the 
environmental conditions. Again, the correlation resulting from the environmental causes is the 
overall effect of all the environmental factors that vary; some may tend to cause a positive 
correlation, others a negative one. The association between two characters that can be directly 
observed is the correlation of phenotypic values, or the phenotypic correlation. This is 
determined from the measurements of the two characters in a number of individuals of the 
population. It can be shown that the phenotypic covariance is the sum of the genetic and 
environmental covariance, and the genetic and environmental causes of correlation combine 
together to give the phenotypic correlation (59).             
1.4.2 Linkage Analysis 
Linkage analysis dissects the inheritance of the disease or defined phenotype in relation to 
cosegregation of the polymorphic genetic markers within a pedigree. It looks for co-inheritance 
of phenotype and/or genotype in related populations. This procedure can be carried out with a 
series of polymorphic genetic markers. In parametric linkage analysis, the use of the wrong 
model can lead to false linkage or more likely can miss the linkage signal. On the other hand, 
Nonparametric (or model-free) linkage methods make fewer assumptions about the trait model. 
although the assumption that the marker locus model(s) is known without error is still in force. It 
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is less suitable using the parametric linkage analysis for the study of complex diseases such as 
osteoporosis where multigeneration families are difficult to come by and the mode of inheritance 
for the disease is unclear (2).  
Several genome-wide linkage scans have been performed in attempts to identify loci that 
regulate BMD. A variety of study designs and analytical methods have been used, including 
analysis of families with a history of osteoporosis, families or sibling pairs drawn from a 
population, and sibpairs who are discordant for BMD values. Some important QTL for BMD 
identified by genome-wide linkage scan are summarized in Table 4. Few of the genome-wide 
scans so far performed have identified QTL that meet the criteria for genome-wide significance, 
and there has been limited replication of QTL between different studies. Moreover, only one 
gene that regulates susceptibility to osteoporosis has been identified by this approach: the BMP2 
gene, which encodes bone morphogenic protein 2 – an important regulator of osteoblast 
differentiation. Some important findings have emerged from these studies, however, including 
the realization that QTL for regulation of BMD differ at different skeletal sites, are gender 
specific, and may also be age group specific. The lack of replication between studies may simply 
reflect the fact that genes that regulate BMD differ in different populations or that genes that 
predispose to osteoporosis have modest effects, which are difficult to detect by conventional 
linkage analysis. Technical advances such as the development of densely spaced panels of single 
nucleotide polymorphisms for genome-wide scans are likely to improve the chances of detecting 
genes of modest effect size in the future. There is also a prospect that meta-analysis of genome-
wide scans may reveal significant QTL that have not been detected by individual studies (56, 58). 
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1.4.3 Candidate Gene Association Studies 
Candidate gene association studies in osteoporosis have logically tackled the main regulators of 
bone metabolism, such as calciotrophic hormones, bone matrix proteins, steroid hormones and 
local regulators of bone metabolism. Relevant information on candidate genes which have been 
studied so far in relation to the genetics of osteoporosis are summarized in Table 5, together with 
a more detailed discussion below of specific candidate genes which have been the most 
extensively investigated. 
Vitamin D Receptor (VDR): The active metabolites of vitamin D play an important role 
in regulating bone cell function and maintenance of serum calcium homeostasis by binding to the 
VDR and regulating the expression of a number of response genes (62-64).  
            Type I collagen: Type I collagen is the major structural protein of bone, thus the genes 
encoding this protein (COLIA1 and COLIA2) are candidates for the genetic regulation of bone 
mass. 
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Table 4. Chromosomal Regions Implicated in Genome-Wide Linkage Scans of BMD 
 
 
Indeed, deletions or point mutations in these two genes have been identified as the molecular 
basis of up to 90% of cases of osteogenesis imperfecta, a hereditary disease characterised by 
osteoporotic bone and skeletal fracture in early life (65, 66). 
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Estrogen receptor (ESR): Estrogen, by interacting with its receptors in bone and other 
tissues plays an important role in regulating skeletal growth and maintenance of bone mass. 
Knockout mice with null alleles at the ESR locus have reduced BMD compared with wild-type 
controls. Osteoporosis has also been observed in man with an inactivating mutation of the ESR 
gene (67, 68). 
Transforming growth factor beta (TGF): A rare polymorphism in intron 4 of TGF-1 has 
been associated with very low BMD and osteoporotic fracture in one study but the effects on 
TGF function are unclear. Another polymorphism, a C-T transition in a TGF-1 coding region, 
has been described which causes a leucine-proline substitution at amino acid 10. The C allele 
was associated with high BMD and a reduced frequency of osteoporotic fractures in two 
Japanese populations (69). 
Androgen receptor (AR): A polymorphic (AGC)n repeat polymorphism has been 
described in exon 1 of the AR, which codes for a polyglutamine tract in the activation domain of 
the receptor. Length variations in the polymorphism have previously been associated with 
differences in receptor function and large expansions of the tract have been found to cause X-
linked spino-cerebellar muscular atrophy (70). 
 
Other Genes  (71-75)
Osteocalcin: Dohi et al. described a C_T transition in the gene promoter of the 
osteocalcin gene that was related to BMD in a Japanese population but Sowers et al. (1999) 
found no association between this polymorphism and BMD or circulating osteocalcin levels in 
an American population.  
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Apolipoprotein E (ApoE): The human ApoE gene is polymorphic, with three common 
alleles (2, 3, 4) coding for three isoforms (E2, E3, E4) which differ from each other by a single 
amino acid and in their binding affinity for the four ApoE receptors. Shiraki et al. reported that 
BMD values were significantly reduced in Japanese women who carried the ApoE4 allele and a 
recent study in American Caucasian women found an association between the presence of at 
least one ApoE4 allele and hip fracture.  
α2-HS-glycoprotein: α2-HS-glycoprotein (AHSG) is a serum-derived protein that binds 
to bone matrix due to its affinity to hydroxyapatite. Zmuda et al studied the relationship between 
a coding polymorphism of AHSG and osteoporosis in Caucasian women from the USA. The 
polymorphism (AHSG*1 or AHSG*2) was not significantly related to hip, lumbar spine or 
calcaneal BMD but, compared with the homozygous AHSG*2 women, calcaneal broadband 
ultrasound attenuation (BUA) was 13% lower in heterozygous and 16% lower in homozygous 
AHSG*1 women. Height was also reduced in homozygous AHSG*1 women, intermediate in 
heterozygous women, and highest among homozygous AHSG*2 subjects. These results suggest 
that the AHSG polymorphism may contribute to the genetic influence on calcaneal BUA and 
height. 
Interleukin-6 (IL-6): Two studies have looked for evidence of an association between 
BMD and polymorphisms at the IL-6 locus. An AT-rich minisatellite repeat was associated with 
lumbar spine BMD in one study and a polymorphic AC-rich minisatellite was reported to be 
associated with wrist BMD in another. The mechanisms by which these polymorphisms affect 
IL-6 gene function are unclear, but it is possible that they could be mediated by linkage 
disequilibrium with a functional polymorphism that is known to be present in the IL-6 promoter. 
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Calcitonin receptor: A coding polymorphism causing a proline-leucine substitution at 
codon 436 of the calcitonin receptor gene has been described. The relationship between this 
polymorphism and BMD has been studied in French and Italian populations. Masi et al. (1998) 
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reported that individuals homozygous for the leucine substitution had reduced bone mass when 
compared with heterozygotes and praline homozygotes. Taboulet et al. (1998) reported an 
association between BMD and this polymorphism, and found that heterozygotes had higher 
BMD and a reduced risk of fracture when compared with homozygotes. The effects of this 
polymorphism on calcitonin receptor function has not yet been studied. 
1.4.4 Experimental Cross Animals 
To identify QTLs that affect BMD, investigators have crossed inbred animals from a strain that 
shows increased susceptibility to the disease. Linkage studies and allele sharing studies can then 
be performed in the large number of the F2 progeny. Linkage studies in mice have resulted in the 
identification of several QTL that regulate BMD in mice, and the same approach has been used 
to localize QTL for other phenotypes relevant to the pathogenesis of osteoporosis such as 
circulating levels of insulin-like growth factor-1, bone structure, bone shape, and bone strength 
(76). Most investigators have focused on the detection of QTL for BMD regulation, and such loci 
have now been identified on almost all mouse chromosomes, with replication of several QTL 
across different strains. The studies in mice have clearly shown that the genes that regulate BMD 
have effects that are site specific and gender specific (77, 78). Identifying the genes and genetic 
variants responsible for these effects is technically challenging because mouse QTL regions are 
usually large, requiring successive rounds of selective breeding to narrow the region of interest 
to a manageable size. Even then, identification of the causal variants remains difficult because 
the predisposing genetic variant is in complete linkage disequilibrium with all adjacent variants 
on the same chromosomal segment (79, 80).  
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1.5 BONE QUALITY AND ASSESSMENT OF BONE QUALITY  
1.5.1 Bone Quality 
Bone is a geometrically complex and composite material characterized by an elaborate array of 
mechanical properties (81). As such, there is no single property that is adequate to describe “bone 
strength” (82). Although areal BMD is a continuous variable, an operational definition of 
osteoporosis defines the disease as a BMD below 2·5*SD from the mean BMD of young adults 
for skeletal sites such as lumbar spine or proximal femur as evaluated by dual energy X-ray 
absorptiometry (DXA). This phenotypic trait is most commonly used in studies evaluating 
heritability or polymorphic gene markers of osteoporosis. However, in order to understand the 
genetic basis for decreased bone strength, and ultimately osteoporotic fractures, one might 
eventually need to assess the inheritance of, and identify the specific genes associated with, a 
multitude of skeletal and extraskeletal traits, such as bone size, shape and microarchitecture, 
body weight (the single most influential variable correlated with BMD), muscle strength, 
biochemical variables of calcium and phosphate homeostasis, ovarian function, etc. The clinical 
expression of osteoporosis is the skeletal fracture. A fracture is a stochastic event which is 
determined by both bone-related factors (mass, size, architecture, microarchitecture, intrinsic 
properties of bone material) and bone independent factors (falls, protecting responses, soft tissue 
padding, etc.). The latter may have their own heritable and non-heritable components, which 
increases even further the complexity of the genetic determination of osteoporotic fractures (83). 
The operational definition of bone quality is proposed to be the “totality of features and 
characteristics that influence a bone’s ability to resist fracture” (82), that is the set of 
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characteristics that influence bone strength. The Bone Quality Framework was developed as a 
means of describing how bone strength is determined by the overall quality of bone (structural 
and material properties), which is affected by the rate of bone turnover (Figure 1). The structural 
properties of bone include its geometry (size and shape) as well as its microarchitecture 
(trabecular architecture and cortical thickness/porosity). The material properties of bone include 
its mineral and collagen composition as well as the number, size, and localization of micro-
damage. The bone turnover rate is a function of the bone renewal process (modeling and 
remodeling) in which old or damaged bone is resorbed and new bone is created to replace it (22). 
 
1.5.2 Structural Properties 
Geometry: The size of bone appears to have an effect on overall fragility. Vertebral bone size has 
been found to be reduced in women with spinal fractures, and 50% of the deficit in bone mineral 
content is the result of a reduction in bone size. Smaller bone size was also observed when 
patients with spinal fractures were matched with controls with the same areal BMD. Similarly, 
femoral strength is partly a function of the hip axis length, which could be used as a marker for 
the ability of the femur to absorb the impact of a fall. The geometry of bone affects the 
distribution of bone mass. Changing the distribution of mass can change the ability of bone to 
resist bending and torsion. This change would not, however, be reflected in a BMD measurement 
(84). 
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 Figure 1. The Bone Quality Framework 
 
Microarchitecture: At the tissue level, the microarchitecture of bone is an important 
structural property. Microarchitecture can be understood in terms of trabecular architecture 
(which itself can be understood as the orientation, thickness, and spacing of the trabeculae, as 
well as the extent to which the trabeculae are interconnected) and cortical thickness and integrity. 
From a mechanical point of view, trabecular failure (buckling and bending) occurs if there has 
been a reduction in trabecular elements that are perpendicular to the direction of the load. In 
terms of cancellous architecture, bone that is distributed as widely separated, disconnected thick 
trabeculae is less competent than an equivalent amount of more numerous, connected and thin 
trabeculae. The trabecular architecture of bone is particularly important to bone strength. A study 
that examined the trabecular architecture in osteopenic women and men of similar bone mass, 
with and without vertebral fracture, found that patients with fracture had four times the number 
of broken trabeculae as women without fractures. A study that modeled the loss of trabecular 
bone predicted that the loss of individual trabeculae has a greater impact on bone strength than 
the same amount of bone loss attributed to trabecular thinning. An intact trabecular network 
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appears to be vital for maintaining maximum bone strength. The function of trabecular bone is to 
transfer loads across joints such as the hip, and to resist compression, as in the spine. Bone is 
made up of both trabecular and cortical areas, and the proportion of trabecular bone varies from 
site to site. The femoral neck of the hip consists of 25% trabecular bone, whereas in a vertebral 
body the percentage ranges from 66% to 90%. Most of the bone mass that is lost in 
postmenopausal women is from the deterioration of trabecular bone. This is most likely the result 
of the more rapid rate of bone turnover in trabecular bone compared with cortical bone) The 
negative effect of remodeling is a result of hormonal changes, and the loss of trabecular 
horizontal links results in an irreversible loss of structural integrity. Because the amount of 
trabecular bone in the vertebrae is so high, this deterioration is particularly apparent in the spine 
and manifests as compression fractures.  
Bell et al. suggested a novel mechanism for increased cortical porosity in patients with 
hip fracture, which appears to depend on the presence of giant canals in the femoral neck. These 
canals are related to clusters of remodeling osteons, building blocks of bone that are composed of 
a series of concentric rings of bone cells and bone matrix, surrounding a hole filled with blood 
vessels and nerves. The researchers investigated the relationship between remodeling and bone 
loss, osteon diameter; wall thickness, and osteoid width in the femoral neck of patients with hip 
fracture and compared these parameters with age- and gender-matched healthy controls. 
Composite osteonal systems were nearly twice as prevalent in patients with fractures and had 
significantly thinner walls. This study suggests that the principal remodeling deficit in hip 
fracture is specific to composite osteons, which leads to increased porosity of cortical bone (85, 86). 
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1.5.3 Material Properties 
Bone tissue is composed principally of inorganic bone apatite crystals that mineralize an organic 
type I collagen matrix. The degree of mineralization, the material properties of the collagen 
matrix, crystal size, and the mineral-to-matrix ratio are all important for bone strength.  
Mineral: The degree of mineralization of bone has an important influence on bone 
strength. Follet and colleagues showed that a greater degree of mineralization of cancellous bone 
led to greater stiffness and compressive strength. The degree of mineralization depends on the 
rate of remodeling, which may explain the observation that an increased degree of mineralization 
increases bone strength, while bone matrix volume and microarchitecture remain unchanged. 
Bone mineralization density distribution depends on the remodeling activities of bone cells and 
the time course of mineralization of newly formed bone matrix. Bone densitometry 
measurements reflect the degree of mineralization of the bone and cannot distinguish whether the 
drop in density is the result of lost bone mass along with its mineral content, or whether bone 
turnover is occurring at a higher rate and replacing more mineralized old bone with less 
mineralized new bone. In other words, BMD and the degree of mineralization are not 
interchangeable. The collagen matrix of bone is not uniformly mineralized; rather it exhibits a 
range of mineral concentration, determined by the duration of the secondary mineralization of 
individual bone packets. This effect has been demonstrated by microradiography and back-
scattered electron imaging. In bone, mineral particles are strongly oriented in the direction of 
collagen fibers as determined by X-ray diffraction. The ultrastructural organization of mineral 
particles may influence toughness and the elastic modulus or mechanical properties of the whole 
bone (87-89).  
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Collagen: One of the most distinctive characteristics of type I collagen, as found in 
mineralized tissue, is the chemistry of its cross-links. A study by Oxlund and colleagues showed 
that bone collagen from cancellous vertebral bone taken from deceased individuals with 
osteoporosis showed increased extractability and a substantial reduction in the concentration of 
divalent reducible collagen cross-links compared with age and gender matched controls. The 
extractability of bone collagen depends on molecular packing, noncovalent intermolecular 
forces, and cross-links between collagen molecules. There was a reduced concentration of known 
collagen cross-links in bone from individuals with osteoporosis. This change could result in a 
reduction of the material strength of the bone trabeculae and explain why the individuals with 
osteoporosis had fractures even though they had a similar amount of trabecular bone as the 
healthy controls (90). 
1.5.4 Bone Turnover 
Bone is not a static material, but a complex living tissue that undergoes constant renewal to 
repair the microdamage that occurs on a daily basis. Bone turnover or remodeling, is a crucial 
process of bone renewal that most likely occurs at an optimal physiologic rate for maximum 
bone strength in a healthy individual. New bone tissue is created during the growth period of the 
human skeleton. As the bone grows, the mass of bone inside the periosteal envelope develops 
into a cortex. Once longitudinal bone growth has stopped and peak bone size and BMD have 
been reached, bone renewal or remodeling continues on the endosteal surfaces. Osteoclasts 
resorb damaged bone tissue, which results in a resorptive cavity on the trabecular and 
endocortical surfaces, or a cutting cone within the cortex. The resorption cavity is subsequently 
filled with new bone by osteoblasts. The new bone undergoes first a rapid primary and then a 
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slower secondary phase of mineralization. As long as the rates of bone resorption and bone 
replacement are balanced, neither a net loss of bone nor an increase in damaged bone occurs (91).  
1.5.5 Assessment of Bone Quality 
A large body of epidemiologic data indicate that despite its limitations, the current standard for 
predicting fracture risk is an areal BMD measurement by dual-energy X-ray absorptiometry 
(DXA) (92, 93). However, BMD measurements reflect only one aspect of bone quality, the quantity 
of bone per area. There exists great disparity between the information provided by BMD and that 
required to improve the diagnosis and treatment of osteoporosis. New imaging modalities and 
biomarkers capable of assessing various components of bone quality have the potential to 
provide information required to improve the diagnosis of osteoporosis, prediction of future 
fracture risk and monitoring of treatment response. Hence, there is a clear need for the 
development of more sensitive risk assessment tools in addition to BMD. Considerable progress 
has been made in the development of noninvasive methods to assess the skeleton, so that 
osteoporosis can be detected early, its progression and response to therapy monitored carefully, 
and its risk effectively ascertained. The capability now exists to evaluate the peripheral, central, 
or entire skeleton as well as the trabecular bone or cortical bone envelopes accurately and 
precisely, with the capacity to determine bone strength and predict fracture risk. A variety of 
techniques are currently available to assess the skeleton noninvasively: radiographic 
absorptiometry, single photon and single X-ray absorptiometry, dual photon and dual X-ray 
absorptiometry, standard quantitative computed tomography (QCT) and peripheral QCT, 
quantitative ultrasound (QUS), and magnetic resonance microscopy (mMR). Of these 
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techniques, only the latter three—QCT, QUS, and mMR—have substantial potential to provide 
information about bone quality and structure beyond bone mineral density (BMD).  
 
DXA  
Dual-energy X-ray absorptiometry (DXA), a two-dimensional measurement (33),  is now 
one of the most frequently used techniques for body composition measurement as a result of the 
increasing worldwide availability of these scanners (Figs.2 and 3). The technique is attractive 
because it is non-invasive, is easily applied for both healthy individuals and patients, and the 
radiation dose is extremely small. Scanning times, which may have been an impediment to its 
use in pediatric studies, have decreased substantially with newer technology. A further attractive 
feature is its ability to provide regional-body composition analysis 10.  
 
 
Figure 2. Bone Measurements by DXA 
 
 
DEXA is capable of good precision for the measurement of body fat, fat-free mass and bone 
mineral, and this has been well documented 31, 32. This attribute makes it potentially a valuable 
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tool for longitudinal studies in the clinical setting. DEXA accuracy is more difficult to judge, 
partly because of lacking a technique for direct measurement. Postmortem chemical analysis of 
animals has been compared with DEXA measurements in a number of studies, with variable 
results depending on the equipment and software used (34-36).  
 
QCT 
The validity of quantitative computed tomography (QCT) for measuring vertebral 
cancellous bone is widely accepted and it is used worldwide (37). QCT can determine in three 
dimensions the true volumetric density (mg/cm3) of trabecular or cortical bone at any skeletal 
site. Because of the high responsiveness of trabecular bone and its importance for vertebral 
strength, QCT has been employed principally to determine trabecular bone density in the 
vertebral centrum. In this application, QCT has been used to assess vertebral fracture risk (38, 39), 
measure age-related bone loss (11, 12, 40), and follow the progression of osteoporosis and other 
metabolic bone diseases (41). In general, spinal QCT is performed with standard clinical 
computed tomography (CT) scanners, and an external bone mineral reference phantom is used to 
calibrate the CT number measurements to bone-equivalent values. Typically, special software is 
employed to automatically place regions of interest inside the vertebral body. 
Special purpose peripheral QCT (pQCT) scanners have been employed for measurements 
of bone mineral content (BMC) and BMD of peripheral skeleton. pQCT allows for a true 
volumetric measurement of appendicular cortical and trabecular bone and provides three-
dimensional localization of the target volume (Figs.4 and 5). Ease of use, the ability to separately 
assess cortical and trabecular bone and to measure BMD, BMC, and cross-sectional area of both 
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bone and muscle make the method an interesting alternative to the technique of single- and dual-
energy X-ray absorptiometry (DXA). 
 
Figure 3. Bone Measurements by pQCT 
 
There are many advantages of pQCT measurements over DXA. First, pQCT is capable of 
three-dimensional imaging, which can provide information on the architecture of bone. It offers 
an attractive possibility to noninvasively determine bone mechanical properties. This procedure 
allows assessment of not only the geometric properties (including CSMI- cross-sectional moment 
of inertia), but also the "true", volumetric mineral density (vCtBMD) of the cortical region of any 
long bone. Assuming proportionality between elastic modulus in bending and vCtBMD or 
cortical bone within the experimental range, the latter could be regarded as an indirect indicator 
of (cortical) bone material quality in mechanical terms. The CSMI, on the other hand, is an 
architectural indicator (for bending or torsion analysis) by itself. Hence pQCT noninvasively 
evaluates both the mechanostatic behavior and the mechanical properties of long bones under 
any experimental condition. In addition, it allows determination of the material property of the 
bone, by estimation of the bone mass per volume unit. DXA densitometry only measures bone 
“mass” and does not inform about bone material quality and architectural design 11, 37. Peripheral 
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QCT measurements of BMD at the radius have been found to be successful in distinguishing 
between osteoporotic and nonosteoporotic patients and in monitoring subjects during clinical 
studies (42). 
1.5.6 Biomarkers 
Besides the noninvasive imaging technology discussed above, scientists also use biomarkers to 
assess bone quality (94-96). Currently available biochemical indices of bone turnover, particularly 
those of bone resorption, predict fracture risk independently of BMD and have been shown to 
account for a substantial proportion of the reduction in fracture risk following antiresorptive 
therapy. It is not clear whether these markers directly reflect aspects of skeletal fragility or 
whether they indirectly reflect skeletal traits, such as increased cortical porosity, cortical thinning 
and degradation of the trabecular network, which are consequences of increased resorption. 
1.6 TOBAGO POPULATION AND FAMILY STUDY  
The country, Trinidad & Tobago (T&T) is an independent democracy and English is the 
principal language.  The two main islands of this country lie at the southern end of the Caribbean 
archipelago.  Tobago (Fig. 6), the smaller island (7 by 29 miles, 1994 estimated population 
50,744), lies 60 miles northeast of the  island of  Trinidad (45 by 45 miles, current estimated 
population 1,272,385) (97-98).  
The population of Tobago was reported to be 92 percent black, 4.5 percent mixed, 2 
percent East Indian, 0.4 percent white, 1 percent other in the 1990 census.   This distribution is 
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very different from the 38 percent black, 20 percent mixed, 42 percent East Indian, and 0.3 
percent white/other reported in the total Trinidad & Tobago population. The older population of 
the island appears to be a stable population of descendents of West African forbearers who 
arrived around 200 years ago.  They are thought to share considerable West African Ancestry 
with African Americans.  The Tobago population of non-African descent has been very small 
throughout this time period, and genetic admixture is estimated to be relatively low 99.  This low 
admixture rate will allow us to focus more sharply on the genes of West African descent than is 
possible in most populations outside of West Africa. 
As part of a large population-based prostate cancer surveillance project of all age-eligible 
men on the Caribbean island of Tobago (18), in our Tobago family study we recorded the number 
of living siblings for each participant, as well as the vital status and residence of their parents. 
These data revealed that the sibship size in Tobago is large, with a median living sibship size of 
8. To date, we recruited 471 individuals age 18 and older in eight multigenerational families of 
the following sizes: 102, 26, 49, 28, 113, 21, 38, and 94, with a mean family size of >50 
individuals. These 284 women and 187 men with phenotype data ranged in age from 18-103 
years (mean age, 43 years). Among these 471 individuals in eight pedigrees we have thousands 
of different relationship pairs.  
 
 
Figure 4. Map of Tobago Island 
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1.7 INTRODUCTION TO THE METHODOLOGY 
The major objective of this PhD project is to disentangle the genetic and environmental 
components that influence bone strength-related traits.  Furthermore, I wanted to identify traits 
that were significantly heritable, because these traits are usually chosen for subsequent genetic 
analysis such as linkage or association study. Several different methods can be used to estimate 
heritability, and all use the theoretical correlations between relatives.  As described below, I 
chose the variance component approach, as implemented in SOLAR, beause it has the capability 
to handle large, multigenerational pedigrees  (100, 101). 
In addition to characterizing the influence of genetic and environmental factors on one 
trait (univariate analyses) , we also know that a common gene or common sets of genes might 
influence two or more traits, i.e. there might be pleiotropy. The relative magnitude of a 
pleiotropy effect on two traits can be measured by estimating  the genetic correlation (ρ g) 
between two traits using bivariate analyses, as described below.    
General speaking, under the variance component framework, the level of any phenotype, 
y, for individual i can be modeled as  
y = µ + Σ βi Xij + gi + ei    (102)
where µ is the mean of the trait, Xij is the j-th covariate for the ith individual, βi is its regression 
coefficient, and gi and ei represent the random deviations from m for individual i that are 
attributable to additive genetic and residual error effects, respectively. The residual error 
component includes true random error, measurement error, and any non-additive genetic 
components. The effects of gi and ei are uncorrelated and normally distributed with mean zero 
and variances σ 2g and σ 2e respectively. The σ 2e term represents the residual environmental 
variance, after accounting for the effects of measured covariates. Maximum likelihood methods 
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were used to simultaneously estimate the mean and variances as well as the covariate and genetic 
effects.  
For a simple additive genetic model, the covariance matrix for a pedigree can be written 
as  
             Ω = 2 Φ σ 2g + I σ 2e  
where Φ is the kinship coefficient matrix and I is an identity matrix.  The proportion of the total 
phenotypic variation in any phenotype that could be attributable to additive genetic effects (σ 2g / 
(σ 2g + σ 2e)) corresponds to ‘‘narrow’’ sense heritability (h2) since it reflects the degree of 
additive genetic variance only. 
h2   (Narrow sense heritability) = σ 2g / σ 2p = σ 2g / (σ 2g + σ 2e) 
This is how we estimated the heritability for all of our bone traits in the subsequent chapters. In 
fact, in our study we directly estimate residual (h2r) instead of h2. Residual heritability represents 
the proportion of the residual phenotypic variation due to additive genetic effects (after removing 
the effects due to measured covariates). The relationship between these two terms can be 
expressed by   
 h2r = h2 / (1- R2) 
where R2 is the proportion of total phenotypic variation explained by the measured covariates.   
 The extenstion of the univariate analyses described above to the bivariate analyses that 
we preformed (or more generally, multivariate analyses) is straightforward. The covariance 
matrix for the pedigree for the multivariate analysis can be written as 
  Ω =  G  2 Φ + E   I⊗ ⊗ n  (103)
where   is the Kronecker product operator, G is the residual additive genetic covariance matrix, 
and E is the (unmeasured) environmental covariance matrix. For the bivariate analyses that we 
⊗
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performed, we first obtained trait-specific estimates of σ 2g and σ 2e , , that is, σ 2g1 , σ 2g2 and σ 2e 1 
, σ 2e 2 ,  We also estimated the additive genetic,  ρ g , and (unmeasured) environmental, ρ e , 
correlations between the two traits. We then determined whether any phenotypic covariation 
between the traits was attributable to genetic and/or environmental factors.  In other words, we 
tested the null hypotheses that there was no genetic correlation (that is, ρ g = 0 versus ρ g ≠ 0) 
and/or no environmental correlation (that is, ρ e = 0 versus ρ e ≠ 0). rg ~ 1 means two traits share 
almost identical genetic determinants and rg ~ 0 means there are unique genes or genetic factors 
which control these two traits separately. The negative rg has the similar interpretation as 
positive ones except that the genetic effects might drive the trait on the opposite directions.  
1.8 SPECIFIC AIMS 
The specific aims of my dissertation proposal are given below. The corresponding analyses and 
results to these aims/hypothesis were will be presented in subsequent chapters. 
 
Aim 1: Dissect the genetic architecture of bone strength phenotypes in families of African  
             heritage. (Chapter II) 
(1-A) For environmental factors: Age, Sex, Smoking, Alcohol Drinking, Physical 
Activities, female menopause status and together with some other important anthropometric, 
life-style, medication etc. factors will be treated and controlled as a risk factor (including main 
effect and some of the interaction). Significant covariates and R2 will be evaluated by stepwise 
regression in R and SOLAR. 
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(1-B) For genetic impact: SOLAR, genetic software which can handle multi-generation 
pedigrees will be used to estimate residual heritability (h2r).  
 
Aim 2: Estimate the extent of possible pleiotropic effects of genes on BMD and bone  
             geometry phenotypes. (Chapter III) 
 
Aim 3: Develop “composite traits” (or “combined phenotypes”) by two multivariate  
             analysis methods-- Principal Component Analysis and Factor Analysis.  
             (Chapter V and IV)   
(3-A) Compare results from Principal Component Analysis and Factor Analysis applied 
to simulated family data. (Chapter V) 
(3-B) Derive composite traits by multivariate analysis, using data on bone quality related 
phenotypes, from the Tobago Family Health Study. (Chapter VI)  
 
Aim 4: Test for association between bone quality related traits (including composite traits) 





2.0  GENETIC AND ENVIRONMENTAL DETERMINANTS OF VOLUMETRICAND 
AREAL BONE DENSITY IN TOBAGO MULTI-GENERATIONAL FAMILIES 
In this chapter, we determined the extent to which genes (heredity) and environmental factors 
contribute to both areal and volumetric BMD phenotypes within families of African ancestry 
(Tobago Population). In addition, we assessed a number of environmental factors of probable 
importance to skeletal health, including diet, physical activity, anthropometric characteristics, 
body composition, medication use and medical status. The analysis was based on 471 individuals 
in 8 extended multigenerational families of African descent. We used quantitative genetic 
methods to determine which environmental factors influence 12 BMD traits, as well as the 
relative influence of genes on these phenotypes. Several interesting findings include: 1) Areal 
BMD at the femoral neck and hip was highest in the Afro-Caribbean men and women at all ages 
compared to U.S. black and white population.  2) Trabecular volumetric BMD and cortical 
volumetric BMD decreased at different pattern across age and gender; 3) Anthropometric, 
lifestyle, and medical factors accounted for 12-38% of the variation in areal and volumetric 
BMD. Among them, sex, height and weight accounted for the majority (73% to 99%) of the total 
variation due to significant covariates, and 4) Residual heritabilities (range 0.29-0.70) were 
similar to those reported in other ethnic groups. Heritability of cortical BMD was substantially 
lower than that of areal or trabecular volumetric BMD. All detailed methods, results and 
discussions associated with this chapter were summarized and published in Journal of Bone 
 34 
Mineral Research (Wang X, Kammerer CM, Wheeler VW, Patrick AL, Bunker CH, Zmuda JM 
22(4):527-536, 2007); please refer to it as below.    
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Osteoporosis is a systemic skeletal disorder characterized by low bone mass and 
microarchitectural deterioration of bone with a consequent increase in bone fragility and 
susceptibility to fractures(1). Bone mineral density (BMD) is one of the most important indicators 
of the mechanical strength of the skeleton and the risk of osteoporosis related fractures. BMD 
can be assessed by two-dimensional dual energy X-ray absorptiometry (DXA) or by three-
dimensional computed tomography.  Quantitative computed tomography (QCT) may provide 
several advantages over DXA for the assessment of BMD.  First, QCT is a three-dimensional 
technique that measures BMD volumetrically (g/cm3) and is independent of the potential 
confounding effects of bone size. Bone volume estimates derived from DXA images have been 
proposed (2), but are thought to be of limited use. Second, QCT directly examines the trabecular 
and cortical bone compartments separately whereas DXA yields a measure of integral BMD (i.e., 
cortical and trabecular) that may be confounded by the high prevalence of extra-vertebral 
mineralization among older adults (e.g., osteophytes)(3-6). Further, measures of trabecular BMD 
may confer the highest risk for vertebral fracture (7,8) and are more sensitive to changes in bone 
metabolism.  
Many intrinsic and extrinsic factors have been correlated with areal BMD, including 
heredity, age, gender, body mass index, sex steroid hormones, physical activity, calcium intake, 
and diabetes(9-13).  However, most heritability studies have relied solely on DXA measures of 
integral BMD; none to our knowledge have comprehensively dissected the relative contribution 
of genetics and environmental factors to the determination of trabecular and cortical volumetric 
BMD as measured with QCT.  Furthermore, although several studies report that populations of 
African ancestry have substantially higher BMD and lower osteoporotic fracture risk than other 
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ethnic groups (14-17), there is a paucity of information about the genetic and environmental factors 
that contribute to skeletal health in populations of African origin. Thus, dissection of the genetic 
architecture of QCT measures of volumetric BMD, especially in populations of African heritage, 
is important to advance our understanding of the etiology of osteoporosis. 
In the current study, we investigated the genetic and environmental contributions to areal 
BMD measured by traditional DXA as well as volumetric BMD measured by peripheral QCT in 
471 individuals from 8 large, multigenerational Afro-Caribbean families.  We also compared our 
results to those obtained in populations of European descent and African Americans. 
2.2 MATERIALS AND METHODS 
2.2.1 Study Samples 
As part of a large population-based prostate cancer surveillance project of all age-eligible men on 
the Caribbean island of Tobago (18), we recorded the number of living siblings for each 
participant, as well as the vital status and residence of their parents. These data revealed that the 
sibship size in Tobago is large, with a median living sibship size of 8.  
 
Thus, the men in our population-based study served as potential probands for the family 
study, and were selected without regard to medical history or BMD.  To be eligible, a proband 
had to be a healthy Afro-Caribbean resident, have had a spouse who was willing to participate in 
the study, and have at least six living offspring and/or siblings aged 18+ years who were residing 
in Tobago. These potential probands were sorted by family size, and individuals with the largest 
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family sizes were recruited first. All eight probands for the Tobago Family Health Study were 
between 52-103 years of age and none of them had previously been diagnosed with prostate or 
any other cancer. In addition, all first-, second- and third-degree relatives of these probands and 
their spouses were invited to participate regardless of their medical history or BMD. To date, we 
recruited 471 individuals age 18 and older in eight multigenerational families of the following 
sizes: 102, 26, 49, 28, 113, 21, 38, and 94, with a mean family size of >50 individuals. These 283 
women and 188 men with phenotype data ranged in age from 18-103 years (mean age, 43 years). 
Among these 471 individuals in eight pedigrees we have the following relationships:  361 parent-
offspring, 495 full siblings, 101 grandparent-grandchildren, 1137 avuncular, 61 half sibs and 
1380 cousins. Written informed consent was obtained from every participant, using forms and 
procedures approved by the Tobago Ministry of Health and Social Services and University of 
Pittsburgh Institutional Review Boards. 
2.2.2 Peripheral Quantitative Computed Tomography (pQCT) Assessment 
Single axial tomographic slices of the non-dominant forearm and left tibia were scanned using a 
Stratec XCT 2000 scanner (Stratec Medizintechnik, Pforzheim, Germany) according to 
standardized measurement and analysis procedures.  Each scan was acquired with a 0.5-mm 
voxel size, slice thickness of 2.5 mm, and at a speed of 20 mm/s. The precise position of the 
measurement sites were determined in a 30 mm planar scout view using the medial endplate of 
the radius and tibia as standard anatomic landmarks and automatically set by the software at 4% 
(i.e. distal) or 33% (i.e. shaft) of the length of the radius and tibia proximal to the distal endplate. 
These anatomical sites were chosen in order to assess primarily trabecular and cortical bone, 
 38 
respectively. Tibia length was measured from the medial malleolus to the medial condyle of the 
tibia, and forearm length was measured from the olecranon to the ulna styloid process. 
 Image processing was performed using the Stratec software package (Version 5.5E).  All 4% 
ultra distal radius and tibia scans were analyzed using identical parameters for contour finding 
and separation of trabecular and cortical bone (contour mode 2, T=169 mg/cm3; peel mode 1, 
area=45%) to determine the volumetric bone mineral density of the total (mg/cm
3
) and trabecular 
(mg/cm3) bone compartments. All 33% proximal radius and tibia shaft scans were analyzed 
using identical parameters for contour finding and separation of total and cortical bone (contour 
mode 2, T=169 mg/cm3;cortmode 1, T=710 mg/cm3) to determine the volumetric BMD of the 
total (mg/cm
3
) and cortical (mg/cm3) bone compartments.   
The short-term in vivo precision of the separate pQCT measurements for 15 subjects 
ranged from 0.43% (for total density at the distal tibia) to 6.21% (for total density at distal 
radius).  The test-retest correlations for all six pQCT traits ranged between 0.85 (for total density 
at the distal radius) and 0.996 (total density at the distal tibia). A phantom was scanned daily to 
maintain quality assurance. 
2.2.3 Dual Energy X-Ray Absorptiometry (DXA) 
Areal BMD (g/cm2) of the lumbar spine (L1 to L4) and proximal femur (total hip, femoral neck) 
was measured by DXA using the array beam mode on a Hologic QDR 4500W scanner (Hologic, 
Inc.; Bedford, MA). Standardized procedures for participant positioning and scan analysis were 
followed according to the manufacturer’s recommended protocol.  Scans were analyzed with 
QDR software version 8.26a.   
 39 
The short-term in vivo precision of the DXA measurements was assessed in 12 subjects. All CVs 
were less or equal to 1.16% and all test-retest correlations are above 0.99. A phantom was 
scanned daily and reviewed by DXA Resource Group (Worcester, MA) to maintain longitudinal 
quality assurance of the scanner during the course of the study. 
2.2.4 Anthropometry 
Body weight was measured to the nearest 0.1 kilogram with participants wearing indoor clothing 
but without shoes using a balance beam scale.  Standing height was measured to the nearest 0.1 
cm without participants wearing shoes using a wall-mounted stadiometer. The average of two 
measurements was used.  Body mass index was calculated by dividing body weight (kg) by 
height (m2). An inelastic tape measure was used to determine the waist circumference (in cm) at 
the umbilicus.   
2.2.5 Other Measurements  
Information on demographic characteristics, medical history and lifestyle habits was obtained by 
questionnaire and interview by trained and certified clinical staff. Race/ethnicity was based on 
self-declaration and participants provided detailed information on the ethnic origin of their 
parents and grandparents. Respondents were assigned to an ethnic group if they reported that all 
four grandparents as belonged to that group.  The Tobago population is predominantly of West 
African origin (97% of the island according to the most recent census data) with low non-African 
admixture.  Previous studies using molecular markers have confirmed a low admixture (6% non-
African) in this population. (19) 
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Subjects were classified as current smokers (yes/no).  Participants who had smoked fewer than 
100 cigarettes in their lifetime were considered nonsmokers.  Information on alcohol 
consumption was obtained by questionnaire and expressed as drinks per week.  Information on 
calcium and vitamin D supplement use was also obtained (yes/no).  Milk consumption at several 
ages was assessed by questionnaire (20). We assessed caffeine consumption by assuming one cup 
of coffee contained 95 mg of caffeine; tea, 55 mg and colas, 45 mg as previously described(21,22). 
Subjects were asked if they walk for exercise (yes/no). Physical activity was also assessed as a 
continuous variable by the number of minutes walked and hours spent watching television per 
week. 
Reproductive characteristics including ever being pregnant, menopausal status, use of 
hormone therapy and current oral contraceptive use, were recorded (all coded as yes/no). 
Because only 5/283 (1.8%) women reported ever using post-menopausal hormone therapy, we 
did not consider this variable as a potential correlate of BMD in subsequent analyses. Women 
were defined as post-menopausal if they declared that they had no menses for at least 12 months 
and were greater than 40 years old (n=76) or they had experienced a hysterectomy or 
ovariectomy (n=9).   
Participants were asked to bring prescription and non-prescription medications to the 
clinic for verification. Current use was defined as use within the preceding 30 days.  A study-
specific medication dictionary was used to categorize the type of medication from product brand 
and generic names obtained from the medication containers.  Dose or duration of use or specific 
indication was not queried.  Subjects were asked whether a doctor or health care provider had 
ever told them they had certain medical conditions including arthritis, cancer, or cardiovascular 
disease.  Hypertension was defined as a diastolic blood pressure exceeding 90mmHg or systolic 
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blood pressure exceeding 140mmHg (n=91) or currently taking blood pressure medication 
(n=41). Diabetes was defined as fasting glucose level exceeding 126 mg/dl (n=45) or currently 
taking diabetes medication (n=26).  
2.2.6 Statistical Analysis  
Prior to statistical analysis, the distributions of all BMD traits were assessed for non-normality.  
Subsequently, all outliers (± 4 standard deviations) were removed for each BMD trait, and no 
more than 4 values were removed for a single variable.   
The major goal of our analysis was to determine the extent to which genetic and 
environmental factors contribute to the total phenotypic variation of the areal and volumetric 
BMD measures. Initially, to identify possible covariates influencing each BMD trait, we first 
performed combined forward and backward stepwise linear regression analysis, ignoring the 
non-independence of the subjects, using the R statistical package (Version 2.2.1). We required 
each variable remaining in the model to be significant at P≤0.10. We subsequently evaluated 
each of the potentially significant covariates using a variance component framework that enabled 
us to take into account the correlations among family members (13). Briefly, the variance 
components approach involves partitioning the variance of a quantitative trait into components 
attributable to individual-specific covariates (e.g., age, BMI, diabetes status, etc.), an additive 
genetic (polygenic) component, and a residual non-measured environmental component. The 
additive genetic component is modeled as a random effect from the covariance matrix, which is a 
function of the coefficient of relatedness between all pairs of individuals.  For example, two full 
sibs share 1/2 of their genes in common on average, and thus have a coefficient of relatedness 
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equal to 1/2. Thus, the effects of all independent variables on BMD are estimated conditional on 
the correlations among related individuals.  The significance of a particular independent variable 
(e.g., diabetes status) was assessed by the likelihood ratio test, which compares the likelihood of 
a full model (e.g., age, BMI, and diabetes status) to that of a nested model (e.g., age and BMI 
only, with the diabetes status effect constrained to be zero).  Similarly, the significance of the 
residual heritability (h2r), was determined by comparing the likelihood of a model in which h2r 
was estimated, to a nested model in which h2r was constrained to 0. These analyses were 
performed using the program SOLAR(23). In addition to h2r, which represents the proportion of 
the residual phenotypic variation due to additive genetic effects, we also estimated h2, which 
represents the proportion of total phenotypic variation (including variation due to measured 
covariates) that is attributable to additive genetic effects. The relationship between these two 
terms can be expressed by:  h2r = h2 / (1- R2), where R2 is the proportion of total phenotypic 
variation explained by the measured covariates.   
To compare the effects of covariates across all traits, we report the strength of association 
between covariates and the BMD traits as a percent difference in the BMD trait per unit of the 
covariate, instead of the non-standardized beta coefficients. Percent differences in each BMD 
trait for each covariate were calculated as beta coefficient * unit range / mean BMD.  For 
continuous covariates, the unit range was every 5 years for age, every 10 kg for body weight and 
every 8.5 cm (1 SD) for height. The unit range for dichotomous covariates equaled 1 (3). The 
percentage difference between younger and older age groups was calculated as: [(Trait Mean 
60+ age group - Trait Mean 18-29 yrs age group) / Trait Mean 18-29 yrs age group] *100% for 
each gender. 
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All P-values which tested for gender differences were computed using SOLAR univariate 
regression analysis, which accounts for the non-independence of the family data.    
2.3 RESULTS 
2.3.1 Subject Characteristics 
Among the 283 women and 188 men, BMI was higher but waist circumference was similar in 
women than men (P<0.001) (Table 1).  Although the prevalence of cigarette smoking and 
alcohol consumption was higher in men than women, the prevalence of hypertension, diabetes, 
cardiovascular disease and arthritis were comparable in both genders. Mean number of minutes 
walked or time watching TV per week was comparable in men and women.  Current use of 
supplemental vitamin D and calcium and milk consumption were all significantly higher in 
women than in men (P< 0.05).    
2.3.2 Sex Differences in BMD 
Mean areal and volumetric BMD in men and women with and without adjustment for height and 
weight are shown in table 2.  All measures of areal BMD were significantly greater in men than 
in women.  Mean differences in unadjusted areal BMD between men and women ranged from 
0.07 g/cm2 or 7% at the lumbar spine and femoral neck to 0.11 g/cm2 or 10% at the total hip and 
whole body.  The magnitude of this sex difference represents approximately ½ (lumbar spine, 
femoral neck) to 1 full (whole body) standard deviation. These sex differences in areal BMD 
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were only slightly attenuated and remained statistically significant after controlling for height 
and body weight. Sex differences in volumetric BMD were generally greater at the distal than 
proximal (shaft) regions of the radius and tibia and were greater for trabecular than cortical BMD 
(Table 2).  Trabecular volumetric BMD was 14% greater at the distal radius and 7% greater at 
the distal tibia among men than women, differences that represent approximately ¾ and ½ 
standard deviation.  Adjusting for height and body weight had little effect on these results.  
Cortical volumetric BMD, on the other hand, was significantly greater in women than men at the 
radius and tibia. Although these BMD differences were statistically significant and persisted 
after adjustment for height and body weight, they were small (~1%).   
2.3.3 Age Related Patterns in BMD by Sex and Comparisons with Other Populations 
The sex-specific mean BMD values for young participants (age 18 to 29 years) as well as the 
absolute and percentage difference compared to older aged participants (age 60+ years) are 
shown in Table 3.  Consistent with observations for the entire sample (Table 2), the young adult 
Afro-Caribbean men generally had greater areal BMD values than women.  These relative 
differences were largely maintained throughout life (e.g., Figure 1 shows femoral neck BMD; 
other skeletal sites not shown).   
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Table 6. Characteristics of the Afro-Caribbean Family Members by Gender 
(table 1 in this chapter) 
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Table 7. Mean DXA and pQCT BMD Measures in the Afro-Caribbean Family Members by Gender 
(table 2 in this chapter) 
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The largest areal BMD difference between young and old Afro-Caribbean men and 
women was observed at the femoral neck: -11% and -14% over life in men and women, 
respectively.  We also compared the apparent age- and sex-related patterns in BMD at the 
femoral neck in our Afro-Caribbean family members with published values for non-Hispanic 
Blacks and non-Hispanic Whites in the U.S. NHANES III study (Figure 1) (24).  As expected, 
mean areal BMD at the femoral neck decreased in all age and sex groups (Figure 1), and was 
highest among the Afro-Caribbean men and women throughout life.  However, comparison of 
the slopes of the curves across age groups within each gender indicate that Afro-Caribbean men 
and women may lose bone at a similar tempo to U.S. white and black men and women.  A 
similar pattern was observed for total hip BMD (data not shown).  At the lumbar spine in Afro-
Caribbeans, areal BMD increased over life by 14% in men but decreased by 8% in women.  
Lumbar spine BMD data were not available in the U.S. NHANES III survey for comparison. 
 
Figure 5. Mean Femoral Neck Areal BMD by Age and Gender Among Afro-Caribbean, U.S. non-hispanic White and 
U.S. non-hispanic Blacks (Figure 1 in this chapter) 
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Table 8.DXA and pQCT Bone Density Difference by Age Group and Gender 
(table 3 in this chapter) 
 
The apparent decline with age in total volumetric BMD was similar in magnitude at the 
distal radius and distal tibia and somewhat greater in women (-17% to -18%) than men (-11% to 
-12%) (Table 3).  The apparent age-related decline in total volumetric BMD at the radius shaft 
and tibia shaft was also similar in magnitude.  However, the decline with age was much greater 
in women (-10% to -11%) than in men (0.9% to -1%). Separate measures of trabecular and 
cortical volumetric BMD at these skeletal sites also revealed different patterns by sex and 
anatomic region.  For instance, age-related declines in volumetric BMD were greater for 
trabecular than cortical bone, particularly among men. Moreover, the age-related decline in 
trabecular volumetric BMD tended to be greater in men than in women, whereas the decline in 
cortical volumetric BMD was greater in women than in men.     
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 We also plotted the age- and sex-specific mean volumetric BMD at the radius and tibia 
across life for the Afro-Caribbean men and women (Figures 2A and 2B). Mean trabecular 
volumetric BMD (Figure 2A) was higher in men than women at both skeletal sites over life and 
decreased with increasing age in both groups and at both sites. In contrast, cortical volumetric 
BMD at both skeletal sites increased until age 40-49 and was higher in women than men. In 
subsequent age groups, mean cortical BMD decreased markedly in women, whereas it remained 




Figure 6. Mean BMD by Age, Gender and Skeletal Site among Afro-Caribbean men and women  
 (Figure 2 in this chapter) 
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2.3.4 Anthropometric, Lifestyle, Reproductive and Medical Correlates of BMD 
We next investigated the potential correlates of the DXA and pQCT BMD traits. Table 4 
describes the percent difference in BMD for the most important correlates. With a few 
exceptions, areal and volumetric BMD were generally higher in men than in women, decreased 
with increasing age and height, and increased with increasing body weight. In contrast to the 
other BMD traits, volumetric cortical BMD at the radius and tibia decreased with increasing 
body weight. With the exception of total spine and cortical volumetric BMD of the radius and 
tibia, these four factors (age, gender, height, body weight) accounted for the majority (73% to 
99%) of the total variation due to significant covariates (Table 5). 
In addition to these four covariates, post-menopausal women had lower measures of 
BMD than pre-menopausal women. This difference tended to be more prominent for areal BMD 
at the lumbar spine versus proximal femur and for trabecular versus cortical volumetric BMD. 
Parity was associated with greater cortical but not trabecular volumetric BMD at both the radius 
and tibia.  Diabetes was associated with an increased BMD for most DXA and pQCT traits.  
History of hypertension and cardiovascular diseases showed weaker and inconsistent 
associations with BMD phenotypes. We were unable to detect strong associations between BMD 
phenotypes and walking time, TV watching time or supplemental calcium intake.  
2.3.5 Heritability of BMD 
After incorporating all significant covariates, additive genetic effects (residual heritability), 
accounted for 55% to 65% of the remaining variation in areal BMD (Table 4). In contrast, 
residual heritability of trabecular volumetric BMD at the radius and tibia was higher, and  
 51 
Table 9.Environmental Correlates of BMD Phenotypes in Afro-Caribbean Family Members  




accounted for ~70% of the residual variation at these skeletal sites. Residual heritability of 
cortical volumetric BMD was lower than for trabecular volumetric BMD and ranged from 29% 
to 42% of the total residual variation.  Residual heritability of total volumetric BMD at the radius 
and tibia ranged from 46% to 73% of the total residual variation with sites comprised 
predominantly of trabecular bone (distal radius and tibia) having higher residual heritability than 
sites comprised predominantly of cortical bone (radial and tibial shaft). 
Altogether, significant measured covariates explained from 12% to 38% of the total 
phenotypic variation in areal and volumetric BMD (Table 5). Furthermore, the proportion of 
total variation due to additive genetic factors accounted for as much as or more of the total 
phenotypic variation than did measured covariates. Heritability of trabecular BMD was higher 
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than heritability of cortical BMD (e.g., 0.52 versus 0.23 for the radius), although measured 
covariates accounted for a similar proportion (21% to 26%) of the total phenotypic variation for 
each of these traits. 
 
Table 10. Proportion of Total Phenotypic Variation attributable to Genetic and Measured Environmental Factors 
(table 5 in this chapter) 
 
2.4 DISCUSSION 
To our knowledge, the Tobago Family Health Study is the first comprehensive analysis to dissect 
the genetic and environmental factors influencing bone mineral density (BMD) measured by 
both DXA and QCT in families, and it is the largest family study of individuals of African 
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descent to date. Clinical data, including BMD phenotypes and intrinsic and extrinsic 
environmental covariates, were collected on 471 members of 8 multigenerational families with a 
mean family size >50 individuals and with nearly 3,500 relative pairs. Each family had at least 3 
to 4 generations with phenotypic data.  These large families combined with QCT measurements 
enabled us to begin to disentangle the relative contributions of genes (heredity) and environment 
to the determination of integral volumetric BMD as well as volumetric BMD in the cortical and 
trabecular compartments, and also compare our results with those from other populations.  Our 
analyses revealed substantial overall heritability of areal and volumetric BMD with 
heterogeneity by skeletal site and bone compartment. 
Sex-specific areal BMD at the femoral neck was higher at all ages among Afro-
Caribbeans than in non-Hispanic blacks or whites in the U.S. NHANES III cohort (Figure 1).  
Except for the youngest and oldest age groups, mean areal BMD at the femoral neck among 
Afro-Caribbean women was almost as high as or higher than BMD of U.S. black men.  The 
higher BMD in Afro-Caribbeans than in non-Hispanic blacks may reflect lower admixture in the 
Afro-Caribbeans compared to U.S. black, 6% versus 20%, respectively (19),(25). Although areal 
BMD at the femoral neck in U.S. black men is almost as high as that in our Afro-Caribbean 
family members at age 18-29 years, it appears to decrease with age to a larger extent among U.S. 
black men.   Between the 18 to 29 and 60+ age groups, mean femoral neck BMD decreased 
11.1% in Afro-Caribbean men, 15.6% in U.S. white men, and 20.5% in U.S. black men. 
Although the total percent difference in femoral neck areal BMD also was lowest in Afro-
Caribbean women (14.3%), the percent decline for U.S. black women (18.9%) was slightly less 
than that for U.S. white women (20.6% femoral neck) (24).   
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Lumbar spine areal BMD increased across the lifespan among Afro-Caribbean men. 
Similar age-related increases in lumbar spine areal BMD have been noted in other studies (3).  
Manifestations of spinal degenerative disease such as disc space narrowing, vertebral endplate 
sclerosis, and osteophytes at the spinous processes and facet joints are prevalent among the 
elderly and may be more common among older men than women (4,26).  Such degenerative 
changes are likely to increase the apparent BMD measured in the posterior-anterior position 
(8,27,28). 
Skeletal site-specific differences in the decline in volumetric BMD over life may be 
attributable to differences in bone composition (e.g., the relative composition of trabecular and 
cortical bone), mechanical loading (e.g., weight-bearing versus non-weight-bearing), or other 
factors (29). In men and women of European ancestry, volumetric trabecular BMD at both the 
central and peripheral skeleton decreases with increasing age, and this decrease begins before 
mid-life in both sexes. In contrast, volumetric cortical BMD at both the central and peripheral 
skeleton does not appear to change in either sex before mid-life, after which there is a dramatic 
decrease, and this decrease is greater in women than in men  (30).  The overall age patterns in 
volumetric BMD measured at the radius and tibia in our Afro-Caribbrean families are similar to 
those reported by Riggs et al. (2004) in U.S. whites: men had higher mean trabecular BMD than 
women at both bone sites, and mean trabecular BMD decreased earlier and across all age groups.  
Furthermore, similar to a previous report (Riggs et al., 2004), men had lower peak cortical BMD 
at both skeletal sites, and mean cortical BMD did not decrease until after mid-life in either men 
or women. The percent difference between the youngest and oldest age groups was almost twice 
as high among U.S. whites as Afro-Caribbeans, respectively, for trabecular BMD at the radius 
(~29% vs 16%) and the tibia (~24% vs 12%).  Similarly, for cortical BMD, the overall loss 
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between the youngest and oldest age groups was <4% for both Afro-Caribbean men and women 
at the radius and tibia, whereas U.S. men lost ~17% and U.S. women lost ~27% at these sites. 
(30). The reasons for these apparent differences in loss of areal and volumetric BMD across the 
lifespan among these ethnic groups are unknown, but they could be due in part to differences in 
environmental factors (for example, prevalence of smoking and alcohol use are lower among 
these Afro-Caribbeans than among US whites and blacks), genetic variation, or genotype by 
environment interactions.   
We also investigated the heritability of areal and volumetric BMD in our Afro-Caribbean 
families. Unlike several previous family studies which considered only age, gender and BMI 
when estimating heritability, but similar to a study of areal BMD in Mexican Americans (13), we 
examined a large number of potential covariates for BMD.  In general, four covariates, age, sex, 
height, and weight, accounted for most (73% to 99%) of the variation in areal and volumetric 
BMD due to measured covariates.  For three traits, areal BMD at the lumbar spine and cortical 
BMD at the radius and tibia, inclusion of other covariates, especially menopausal status, 
dramatically increased the proportion of total phenotypic variation due to measured covariates. 
Although menopausal status is significantly associated with almost all of the areal and 
volumetric BMD traits, the strongest and most significant associations were with lumbar spine 
BMD and cortical BMD at the radius and tibia.   
We found that smoking was associated with decreased trabecular, but not areal BMD or 
total or cortical volumetric BMD. Several cross-sectional studies (31-33) have found lower BMD 
among current compared with never smokers.  Male smokers had 0.3 standard deviations lower 
femoral neck BMD compared with never smokers in a meta-analysis of 5 published studies, an 
effect size that was similar to that observed among women (31).  Compared with never smokers, 
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past smokers had 5% or 0.3 standard deviations lower calcaneal BMD independent of important 
covariates (34).  Men aged 20-29 years old who smoked had 10% lower hip BMD compared with 
non-smokers, suggesting that smoking may also reduce peak BMD (35).  The lower BMD among 
current smokers persists after adjusting for important covariates including age, body weight, 
alcohol intake, and physical activity. However, our sample size was too small to look for sex by 
smoking effects as reported by Deng and colleagues (36). 
Similar to some investigators (37,38), but not others (39), we observed the slightly 
counterintuitive result that ever-pregnant status (i.e. parity) was associated with increased areal 
BMD.  Although pregnancy is known to be associated with transient decreases in BMD, the 
observation that increased parity in associated with increased BMD is not well understood, 
although it may be due to increases in body weight, intestinal calcium absorption, and later age at 
menopause (26).  Further investigation in our study indicated that ever-pregnant status was 
associated with increased cortical, but not trabecular BMD at both skeletal sites.   
As reported by others  ((40,41), we found that diabetes was associated with increased areal 
and volumetric BMD. The diabetes association was stronger for trabecular than cortical BMD at 
both the radius and tibia.  Furthermore, as described above, we observed that smoking was 
associated with decreased trabecular but not cortical BMD, and parity was associated with 
increased cortical, but not trabecular BMD at both skeletal sites.  Thus, unlike analyses of areal 
BMD, in which conflicting results are often obtained, analyses of volumetric BMD may reveal 
that different bone compartments are being influenced by specific environmental factors and this 
knowledge may lead to a better understanding of the possible mechanisms involved. 
Except for cortical volumetric BMD, residual heritabilities of areal and volumetric BMD 
in our Afro-Caribbean families ranged from 0.55 (for femoral neck) to 0.70 (for radius trabecular 
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BMD).  Similar to family studies in other population groups (13,42), genes accounted for a larger 
proportion of the total variation than did measured covariates in our Afro-Caribbean families. 
We do not know why heritability of cortical volumetric BMD at the radius and tibia was 
considerably lower than that for trabecular volumetric BMD or areal BMD.  The proportion of 
variation due to measured covariates was similar across all volumetric and areal BMD traits, 
indicating that perhaps unmeasured covariates may have a larger effect – or perhaps that we are 
not adequately powered to model the effects of some covariates.  However, we did not observe 
any difference in the magnitude of the effect of measured covariates on loaded (tibia) versus 
unloaded (radius) bones, indicating that the potential effects of unmeasured covariates may not 
be large. 
In conclusion, our study provides the first comprehensive genetic epidemiologic analysis 
of volumetric BMD measured by QCT, and the first analysis of these traits in extended families 
of African descent.  Our findings reveal that genes account for as much or more of the total 
variation in areal and volumetric BMD than do environmental factors, but also that the 
magnitude of the effect of genetic and environmental factors differs between trabecular and 
cortical bone.  Identification of the genetic and environmental determinants of both trabecular 
and cortical bone mass could reveal novel insights into the etiology of osteoporosis.  
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3.0  PLEIOTROPY AND HETEROGENEITY AMONG BONE STRENGTH 
RELATED PHENOTYPES IN EXTENDED PEDIGREES 
In this chapter, we utilized quantitative genetic methods by SOLAR to estimate the extent of the 
possible genetic correlations (ρG, i.e., pleiotropy) among selected phenotypes within families of 
African descent. In particular, we describe the extent to which a common set of genes 
simultaneously affects variation within pQCT measured BMD traits; within traits by bone 
geometry measurements; and between BMD and bone size traits from what we mentioned above. 
When estimating ρG, the common environmental correlation (ρE) as well as the total phenotypic 
correlation (ρP) were automatically estimated (ρE) or derived (ρP) under the variance component 
framework. The common environmental correlation represents the extent to which the co-
variation of two phenotypes affected by shared unmeasured environmental factors. And total 
phenotypic correlation describes the extent of how two phenotypes correlated to each other 
overall in families. Several interesting findings include: 1) Strong positive genetic correlations 
were observed for trabecular or cortical BMD measured at the tibia and radius (ρG >0.82, 
P<0.01); 2) There was no significant correlations observed between trabecular and cortical BMD 
measured within the same anatomical site; 3) Genetic correlations between volumetric BMD and 
bone length and circumference were also not statistically significant. All detailed methods, 
results and discussions associated with this chapter were summarized in the manuscript (in press) 
for Journal of Bone Mineral Research; please refer to it as below. 
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Osteoporosis is a heritable disorder characterized by decreased bone strength and increased risk 
of fracture. Bone mineral density (BMD) is a major determinant of bone strength and 
osteoporotic risk, but factors other than BMD also contribute to bone strength. In particular, bone 
size has important effects on the biomechanical properties of bone independent of BMD.  For 
example, the external diameter of long bones is exponentially related to its strength such that 
even small increments in external bone dimensions have a large influence on bone strength.  For 
the same amount of bone mass, long bones with larger periosteal circumference will have greater 
bending strength compared to bones with smaller periosteal circumference.  Part of the known 
heritable component to bone strength and fracture risk may thus be due to familial influences on 
bone dimensional properties and periosteal circumference. In contrast to our understanding of the 
familial and genetic influences on areal BMD, measured by two-dimensional dual-energy X-ray 
absorptiometry (DXA), considerably less is known about the genetic architecture of bone size 
determined by three-dimensional imaging methods such as quantitative computed tomography 
(QCT). 
Because QCT measures of volumetric BMD are not confounded by bone size, analyses of 
these traits, separately and together, could reveal whether different or similar sets of genes and 
environmental factors affect these two components of bone strength.  Furthermore, the effects of 
genes and environmental factors on bone strength and osteoporosis may be skeletal site-specific.  
For example, individuals with low bone mass at one anatomical region often do not have low 
bone mass at a different anatomical region (1-3). Moreover, murine models indicate that bone 
strength and trabecular and cortical BMD are highly heritable and genetically regulated in a 
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skeletal-site specific manner (4-7), and a better understanding of these observations could reveal 
fundamental mechanisms underlying bone strength.   
In the current study, we used quantitative genetic analysis methods to investigate the 
contribution of genes, shared genes, and shared environments to phenotypic variation in bone 
strength related phenotypes measured by peripheral QCT in extended, multigenerational families 
including measures of volumetric BMD, bone length and periosteal circumference. We tested the 
hypothesis that bone size and BMD are largely regulated by unique (non-shared) sets of genes. 
We also investigated if trabecular and cortical volumetric BMD are largely regulated by different 
genes. 
3.2 MATERIALS AND METHODS 
3.2.1 Study Sample 
As part of a large population-based prostate cancer surveillance project of all age-eligible men on 
the Caribbean island of Tobago (8), we recorded the number of living siblings for each 
participant, as well as the vital status and residence of their parents. The probands were selected 
without regard to medical history or BMD. All eight probands for the Tobago Family Health 
Study were between 52-103 years of age and none had previously been diagnosed with prostate 
or any other cancer. In addition, all first-, second- and third-degree relatives of these probands 
and their spouses were invited to participate regardless of their medical history or BMD. To date, 
we recruited 471 individuals age 18 and older in eight multigenerational families with a mean 
family size of >50 individuals. These 284 women and 187 men with phenotype data ranged in 
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age from 18-103 years (mean age, 43 years). A total of 3,535 different relationship pairs were 
ascertained (9). An example of the pedigree structure is shown in Figure 1. Written informed 
consent was obtained from every participant, using forms and procedures approved by the 
Tobago Division of Health and Social Services and University of Pittsburgh Institutional Review 
Boards.  
3.2.2 Peripheral Quantitative Computed Tomography (pQCT) Assessment 
Single axial tomographic slices of the non-dominant forearm and left tibia were scanned using a 
Stratec XCT 2000 scanner (Stratec Medizintechnik, Pforzheim, Germany) according to 
standardized measurement and analysis procedures.  Each scan was acquired with a 0.5-mm 
voxel size, slice thickness of 2.5 mm, and at a speed of 20 mm/s. The precise position of the 
measurement sites were determined in a 30 mm planar scout view using the medial endplate of 
the radius and tibia as standard anatomic landmarks and automatically set by the software at 4% 
or 33% of the length of the radius and tibia proximal to the distal endplate. These anatomical 
sites were chosen in order to assess primarily trabecular and cortical bone, respectively. Tibia 
length was measured from the medial malleolus to the medial condyle of the tibia, and forearm 
length was measured from the olecranon to the ulna styloid process.  
 Image processing was performed using the Stratec software package (Version 5.5E).  All 
4% ultra distal radius and tibia scans were analyzed using identical parameters for contour 
finding trabecular (mg/cm3) bone compartments. All 33% proximal radius and tibia shaft scans 
were analyzed using identical parameters to determine the volumetric BMD of cortical (mg/cm3) 
bone compartments. Periosteal circumference (PC) was measured using a scan through the 
diaphysis (at 33% of the bone length in the proximal direction of the distal end of the bone) of the 
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radius and tibia using the circular ring model. The short-term in vivo precision of the pQCT mea-
surements was evaluated in 30 subjects. All CVs for measures of pQCT BMD and periosteal 
circumference were ≤2.1 %. 
3.2.3 Anthropometry 
Body weight was measured to the nearest 0.1 kilogram with participants wearing indoor clothing 
but without shoes using a balance beam scale. Standing height was measured to the nearest 0.1 
cm without participants wearing shoes using a wall-mounted stadiometer. The average of two 
measurements was used in analysis. Seated height was measured to the nearest centimeter with 
the participant seated on a stool against a wall-mounted stadiometer. Trunk length (cm) was 
estimated as the seated height minus the height of the stool. Leg length (cm) was estimated as the 
difference between standing height and trunk length.  Body mass index was calculated by 
dividing body weight (kg) by height (m2).  
3.2.4 Measurements of Covariates 
Information on demographic characteristics, medical history and lifestyle habits was obtained by 
questionnaire administered by trained and certified clinical staff.  Our choice of potential 
correlates for phenotypes was based on our previous studies and from the literature (10-12). A 
detailed description of all of the covariates was reported previously (9). Briefly, subjects were 
classified as current smokers (yes/no) and participants who had smoked fewer than 100 
cigarettes in their lifetime were considered nonsmokers. Information on alcohol consumption 
was obtained by questionnaire and expressed as drinks per week. Subjects were asked whether a 
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doctor or health care provider had ever told them they had certain medical conditions including 
arthritis, diabetes, hypertension or cardiovascular disease. Hypertension was defined as a 
diastolic blood pressure exceeding 90 mm Hg or systolic blood pressure exceeding 140 mm Hg 
or currently taking blood pressure medication (n=41). Diabetes was defined as fasting glucose 
level exceeding 126 mg/dl (n=45) or currently taking diabetes medication (n=26). 
3.2.5 Statistical Analysis 
We first assessed the distributions of all the traits and, if necessary, performed transformations 
(log, square root etc.) to reduce non-normality.  Subsequently, all outliers (± 4 standard 
deviations) were removed for each trait, and no more than 3 values were removed for a single 
variable.  
 Prior to our estimation of heritability, we performed combined forward and reverse 
stepwise linear regression analysis on all data, using the R statistical package (Version 2.4.0). 
We required each variable remaining in the model to be significant at a less stringent P value 
(P≤0.10) initially. This step was performed ignoring the non-independence of the subjects. 
However, we subsequently evaluated each of the potentially significant covariates using a 
variance component framework that enabled us to take into account the correlations among 
family members. Covariates were treated as significant if the corresponding P value was less or 
equal to 0.05.  
Heritabilities were estimated under the variance component framework using SOLAR 
(Sequential Oligogenic Linkage Analysis Routines) (13), which  partitions the variance of a 
quantitative trait into components attributable to individual-specific covariates (e.g., age, BMI, 
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diabetes status, etc.), an additive genetic (polygenic) component, and a residual non-measured 
environmental component. 
          Genetic correlations were assessed using bivariate maximum likelihood methods as 
implemented in SOLAR. In this analysis, the total phenotypic correlation (ρP) between two traits 
was decomposed into the components due to a gene or common sets of genes and shared 
environmental effects. In order to estimate the genetic (ρG) and environmental correlations (ρE) 
for pairs of traits, the matrix of kinship coefficients was generated conditioning on all the related 
individuals within each pedigree. Using standard quantitative genetic methods, the phenotypic 
variance-covariance matrix and its genetic and environmental components were then obtained. 
From these matrices, the genetic correlation ρG was estimated directly. Likelihood ratio statistics 
were used to test the significance of ρG between any pair of traits (14) .  
In bivariate analysis, the genetic cause of correlation (ρG) is chiefly pleiotropy, in which a 
common gene/genes affects two or more phenotypes. The degree of correlation arising from 
pleiotropy describes the extent to which two phenotypes are co-influenced by the same gene or 
common set of genes. On the other hand, the environment correlation (ρE) describes how two 
phenotypes are co-regulated by the same unmeasured (or unadjusted) environmental factors. 
Both ρG and ρE reflect the overall genetic and environmental factors which affect the covariation 
of the two traits.      
The residual phenotypic correlation (ρ P) between two traits is the sum of both residual 
genetic and unmeasured environmental components and is estimated as follows (15): 
                  ρ P= (sqrt(h2r1)* sqrt (h2r2)* ρ G) + sqrt (1- h2r1) * sqrt (1- h2r2)* ρ E 
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 in which h2r1 and h2r2 are residual heritabilities for the two traits; ρ G and ρ E represent 
genetic and environmental correlation between two traits after adjusting for measured covariates. 
We also estimated the proportion of ρP due to shared genetic contributions as [(sqrt(h2r1)* sqrt 
(h2r2)* ρ G)] / ρ P *100%; the relative proportion of phenotypic correlation due to common 
unmeasured environmental factors was calculated similarly. 
In this study, we estimated heritabilities, as well as genetic and environmental 
correlations using two different models. In the base model, we incorporated the effects of age, 
gender and body weight only. In the full model, we incorporated the effects of all potential 
significant covariates reported by previous studies (9-12, 16).  Because the results were similar for 
both models, we report only the results from the base model (Tables 3 to 5).  
3.3 RESULTS 
3.3.1 Subject Characteristics 
Among our 471 participants, BMI was higher (P<0.001) but body weight was similar in women 
and men (Table 1).  Prevalence of cigarette smoking and alcohol consumption was higher in men 
than women; the prevalence of hypertension, diabetes, cardiovascular disease and arthritis were 
comparable in both genders.  
Men had significantly greater trabecular volumetric BMD than women at both the distal 
radius and tibia. However, women had greater cortical volumetric BMD at the radius shaft. 
There was no gender difference in cortical volumetric BMD at the distal tibia. All measures of 
bone size were significantly greater in men than women. 
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 Table 11. Characteristics of  Study Subjects  
 (Table 1 in this chapter) 
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3.3.2 Heritability Estimation 
In Table 2, we present the proportions of total phenotypic variation due to measured covariates 
and residual heritabilities for both the base and full models. For both models, the estimates for 
residual heritabilities (h2r) of trabecular BMD were substantially higher than those for cortical 
BMD. For bone size related traits, the residual heritabilities at the weight bearing skeletal sites 
(tibia length and PC) were higher than the corresponding measures at non-weight bearing 
skeletal sites (radius length and PC).  
3.3.3 Correlations between Trabecular and Cortical BMD 
We also examined the genetic correlation between cortical and trabecular volumetric BMD 
measures to determine the extent to which a common set of genes may influence these distinct 
bone compartments (Table 3). We found that the genetic correlations between the two trabecular 
and two cortical BMD measurements were significantly positive (0.87±0.05 and 0.83±0.12, 
respectively; P<0.01). Moreover, the common genetic correlations were much higher than their 
corresponding shared (unmeasured) environmental correlations (0.48±0.13 and 0.66±0.05, 
respectively). In stark contrast, the genetic and environmental correlations between cortical and 






Table 12. Proportion of Total Phenotypic Variation attributable to Genetic and Measured Environmental Factors  
 (Table 2 in this chapter) 
 
 
3.3.4 Correlations between BMD and Bone Size Phenotypes 
Bone size is a determinant of bone strength independent of BMD. Previous studies in mice 
suggest that genes which contribute to variation in bone size may differ from those that 
contribute to variation in BMD.(17, 18) Thus, we also examined whether a common set of genes 
might have pleiotropic effects on bone size and BMD in our collection of extended families 
(Table 4).  Except for the correlation between periosteal circumference (PC) and cortical BMD at 
the radius shaft, all other correlations were generally low and only marginally (0.10>P>0.05) or 
not statistically significant. The moderate genetic correlation between periosteal circumference 
and cortical BMD at the radius shaft (ρg = -0.44 ± 0.20, P<0.05), indicates that about 20% of the 
covariation between these traits may be attributable to common genetic determinants. Overall, 
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these results indicate that the majority of genes that influence bone size and BMD may be unique 
for each skeletal phenotype. 
 
Table 13. Correlations between Trabecular and Cortical BMD at the Radius and Tibia  
 (Table 3 in this chapter) 
 
3.3.5 Correlations among Bone Size related Phenotypes 
Finally, we also investigated the relationship among the different measures of bone size (Table 
5).  The genetic correlation among the different traits ranged from 0.49± 0.11 (tibia length vs.  
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Table 14. Correlations between Bone Size amd BMD Phenotypes  
 (Table 4 in this chapter) 
 
 
tibia PC) to 0.82 ± 0.06 (radius PC vs tibia PC) (all P-values < 0.01). Thus, approximately 25-
70% of the covariation between measures of bone length or width within and between 
anatomical regions may be attributable to the pleiotropic effects of a common set of genes. The 
corresponding total phenotypic correlations are moderate (-0.09 to 0.43) and common 
unmeasured environmental correlations are not significantly different from zero (All ρE ≤ 0.29 ± 
0.16; P>0.1).  In addition, we assessed the relationship between trunk length and leg length and 
found that the genetic and unmeasured environmental correlations were high, but in opposite 
directions (ρG =0.77 ± 0.11 and ρE = -0.44 ± 0.17; P<0.05). Thus, the phenotypic correlation 
between these two traits was close to zero. 
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Table 15. Correlations between Different Bone Size Measures   






Figure 7. Example of Pedigree in the Tobago Family Health Study (Figure 1 in this chapter) 
4 generation family including 142 family members; 102 filled symbols indicate family members with phenotype data. 
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3.4 DISCUSSION 
The Tobago Family Health Study provided an excellent and unique opportunity to characterize 
the genetic architecture of several bone strength related traits in a population of West African 
heritage, a racial group that has high bone strength but has heretofore been largely under-
represented in osteoporosis research. Tobago is a relatively small island, and the population is 
predominantly of West African origin (97%). (19) Family size is large thus facilitating recruitment 
of extended multi-generational families suitable for genetic studies. The present study also 
provided the first test of the hypothesis that trabecular and cortical volumetric BMD are 
conjointly inherited in humans (i.e., share common genes).  
We found that the positive phenotypic association between volumetric BMD measured at 
the tibia and radius is due in large part both to the effects of shared genes and to shared 
environments.  Our results show that both cortical and trabecular BMD are heritable polygenic 
traits and that the shared genetic correlation is substantially higher than the common 
environment correlation. Although ρG was similar for cortical and trabecular BMD, we also 
estimated the relative proportion of the total phenotypic correlation that was attributable to genes 
(as described in Methods).  The relative genetic contribution to the total phenotypic correlation 
was higher for trabecular BMD (78%) than it was for cortical BMD (28%) mostly because of the 
low residual heritability of cortical BMD.  
On the other hand, our findings suggest that the genes influencing phenotypic variation in 
cortical BMD are largely distinct from those that control trabecular BMD within a given 
anatomical site. Thus, the majority of the phenotypic variation in cortical and trabecular 
volumetric BMD within a skeletal region may be largely due to unique genes for each bone type.  
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These results appear to be inconsistent with studies by Livshits and colleagues (20, 21), who 
reported that a single major locus with pleiotropic effects may affect both phalangeal trabecular 
and cortical areal BMD (measured by hand radiographs).  They also concluded that a single 
major locus (and polygenes) with pleiotropic effects influence measures of areal BMD at the 
femoral neck and lumbar spine.(20)  Possible reasons for the apparent discrepancy between our 
study results include differences in the study populations (Caucasian versus African ancestry), 
skeletal sites examined (hands, hip and spine versus arm and leg) and the different methods used 
to measure BMD (x-rays and areal BMD versus pQCT and volumetric BMD). In addition, 
although bivariate segregation analyses can be powerful, they may also be misleading (22, 23).  
However, our findings are consistent with several studies reporting that loci (both single genes 
and polygenes) may regulate areal BMD in a site-specific manner (14, 24-26)  Furthermore, our 
results in humans are consistent with findings from inbred strains of mice where the distribution 
of bone mineral into the trabecular and cortical compartments was shown to be regulated 
genetically and by distinct loci.(4) Localizing and identifying the genes that contribute uniquely to 
the density and strength of trabecular and cortical bone in humans and animal models may lead 
to fundamental insight on the complex nature of osteoporosis.  
The heritability of body size in humans has been assessed in numerous past studies, but 
has largely been based on measures of total body height. Body size can also be divided into 
components of size such as trunk length, long bone length and bone circumference. These 
aspects of body size have different developmental patterns (27) and might also be affected by 
distinct sets of genes. However, the genetic architecture of specific components of body size has 
not been well defined in humans. Thus, we comprehensively evaluated the heritabilities and 
genetic relationships among different measures of body and bone size.  After adjusting for age, 
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sex and weight, we found evidence for a strong genetic influence on all measures of body and 
bone size with residual heritabilities ranging from 0.32±0.10 (radius) to 0.64±0.09 (tibia) for 
measures of bone length and 0.60±0.09 to 0.74±0.09 for measures of periosteal circumference at 
the tibia and radius shaft, respectively.  We also found a high genetic correlation between 
measures of bone length (ρG = 0.77) and periosteal circumference (ρG=0.82) at the tibia and 
radius (Table 5). These observations suggest that, compared to unmeasured environmental 
factors, common genes have greater impact on the phenotypic covariation in long bone length 
and circumference at different anatomical regions.  
On the other hand, the genetic correlations between measures of bone length and 
circumference, although significantly different from zero, were moderate (ρG=0.49 to 0.53). 
Thus, most of the covariation in long bone length and circumference is not attributable to 
pleiotropic effects.  This result may not be surprising because long bone growth and geometry 
are governed by two distinct biological mechanisms of bone formation.(28) Longitudinal bone 
growth occurs by endochondral ossification at the epiphyseal growth plates by chondrocytes 
whereas radial bone growth at the diaphysis occurs by appositional deposition of cortical bone at 
the periosteum by osteoblasts. Our results are also consistent with analyses of inbred mice which 
have identified distinct genetic loci for femur length and width.(29)  
In addition, we observed low and mostly non-significant genetic correlations between the 
measures of bone size and BMD measured at several different skeletal sites (Table 4). With 
exception of the moderate genetic correlation between periosteal circumference and cortical 
volumetric BMD at the radius, the majority of the phenotypic variation in bone size and BMD 
appears to be due largely to different genes.  These observations are consistent with findings 
from inbred strains of mice where different quantitative trait loci have been identified for 
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periosteal circumference (18) or cross-sectional area (17) versus BMD. Thus, identifying the genes 
contributing to bone strength and osteoporosis will require careful dissection of the genetic 
architecture of both bone size and BMD related traits. Moreover, the identification of specific 
genes for bone size could provide important insight on bone biology and osteoporosis.  
 We assessed the relative contributions of genes and environmental factors using two 
different models: a base model which incorporated age, sex, and body weight and a full model 
which incorporated all significant covariates.  Our results were similar for both models, most 
likely because age, sex, body weight and height account for the majority (73%-99%) of total 
phenotypic variation due to significant covariates in this population (9).   Although the sample 
sizes are small, we also estimated sex specific heritabilities and genetic correlations.  In general, 
the sex-specific estimates were similar in magnitude to each other and to those obtained on the 
overall population, except the standard errors were larger (results not shown).   Therefore, we 
have no strong evidence for sex-specific differences.  However, because our male and female 
sample sizes are small, we have little power to detect such differences in our current families. 
The results of our multivariate analysis not only provide insight into the complex genetic 
architecture of bone strength related traits, but may also have practical implications.  Large 
genetic correlations in multivariate quantitative genetic analyses can help guide genetic mapping 
efforts.  For instance, using a multivariate bone phenotype characterized by cortical BMD at 
different skeletal regions may be advantageous if the pleiotropy was due largely to a few loci.(15) 
Thus, our findings provide a rationale for future multivariate linkage analyses to identify novel 
genetic loci with pleiotropic effects on bone related traits. The present study may also have 
implications for understanding the determinants of bone strength and the etiology of 
osteoporosis. For example, the high polygenic heritabilities and low genetic correlations that we 
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observed between cortical and trabecular BMD within a given anatomic site is consistent with 
osteoporosis being a heterogeneous disorder.  
In conclusion, our results suggest that the density of the skeleton is a highly heritable 
polygenic trait that is under compartment (bone type) specific genetic regulation. Moreover, the 
majority of the phenotypic variation in bone size and density appears to be strongly influenced 
by non-shared genes. Identifying the genes for each of these bone strength related traits may lead 
to a better understanding of the complex nature of osteoporosis and could also impact on the 
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4.0  COMPARISON AND EVALUATION OF MULTIVARIATE ANALYSIS 
STRATEGIES FOR UNCOVING PLEITROPIC FACTORS ON FAMILY DATA 
Evidence for linkage with bone related phenotypes has been reported for multiple chromosomal 
regions. Despite many studies suggesting that bone phenotypes (especially BMD) variation at 
various skeletal sites is governed by shared genetic factors, most previous studies revealed site-
specific peaks, suggesting that minimal genetic pleiotropy (shared genetic determinants) exists 
between these traits. These observations indicate that a relatively small number of genes may 
contribute to an underlying clustering of bone related phenotypes. Identification of these 
common genes and elucidation of their molecular basis will contribute to a better understanding 
and possible treatment for osteoporosis which is a systemic disease.  
Multivariate analysis (MA) methods were widely used since 2001 in an attempt to dissect 
the pleiotropic genetic and environmental basis for complex diseases, such as osteoporosis, 
metabolic syndrome, and asthma.  However, many statistical issues remain unaddressed by these 
reports. First, the selection of either PCA or FA seems arbitrary; none of the groups justified why 
they chose one instead the other. We decided to evaluate the performance of these two 
approaches. In particular, we wanted to assess which method is better able to detect the 
underlying environmental or genetic factors. Second, most reports used raw traits as input 
variable, but a few used residuals after regressing out some important environmental factors. 
Does analysis of residuals significantly improve the ability of PCA or FA methods to detect 
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underlying genetic components? No direct comparisons to answer this question have been 
reported. Third, many groups have compared the heritability of composite traits (obtained from 
PCA or FA) with the original phenotypes. Does higher heritability of the composite trait 
compared to the original phenotype necessarily imply that the composite trait better reflects the 
underlying genetic components and thus increase the chance for detecting underlying genes? No 
literature that we are aware of has addressed this question.          
Hence, the goal of this chapter is to explore the answers to the above three questions 
using simulated data on nuclear families. Several interesting findings include: 1) Both PCA and 
FA behaved qualitatively similar in most cases, although FA performed better to detect 
predominant signals from an underlying trait; 2) Using residuals in the PCA or FA analyses 
greatly increased the probability that PCs or factors detect common genetic components instead 
of common environmental factors, except if there is statistical interaction between genetic and 
environmental factors; 3) There was no predictable relationship between heritabilities obtained 
from composite phenotypes versus original complex traits, however composite trait heritability 
generally reflected the genetic characteristics of the detectable underlying components. All 
detailed methods, results and discussions associated with this chapter were summarized and 
contributed recently to Genetic Epidemiology, titled “A Comparison of Principle Component 
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Numerous studies over the past several decades indicate that genes contribute to the development 
of complex diseases such as osteoporosis, obesity, and diabetes. Many risk factors for these 
diseases (such as bone mineral density, body fat, glucose levels) have been shown to be 
moderately to highly heritable. In recent years, many studies have suggested that a majority of 
these highly heritable traits (risk factors) are governed by a set of common genes (i.e. pleiotropy, 
defined as when two or more phenotypes are co-regulated by a common gene or a common sets 
of genes) [Deng, et al. 2006; Hegele 1997; Li, et al. 2002; Mitchell, et al. 1996]. One piece of 
evidence in support of the above hypothesis is that bivariate linkage analyses of some of these 
traits revealed stronger linkage signals than were obtained from univariate linkage analysis of 
each trait separately [Devoto, et al. 2005; Li, et al. 2006; Livshits, et al. 2004; Martin, et al. 
2004].  
Conventional measurements of these complex disease-related phenotypes produce many 
intercorrelated phenotypes. For example, bone mineral density (BMD) can be measured by 
peripheral Quantitative Computed Tomography (pQCT) at distal and shaft sites for both radius 
and tibia. High phenotypic and genetic correlations are observed from these bone phenotypes due 
to the common contributions from trabecular and cortical components. Therefore it is possible 
that there might be a relatively small number of factors (both genetic and environmental) 
involved in certain metabolic pathways that contribute to variation in an underlying cluster of 
phenotypes. Identification of these common factors and elucidation of their molecular basis 
should contribute to a better understanding of and possible treatment for some complex diseases. 
It is well-known that bivariate and tri-variate genetic analyses are computationally 
intensive. And genetic analyses of more than three traits are beyond our current computational 
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ability. Therefore, multivariate analysis might be an alternative yet effective solution to identify 
common genetic and environmental factors that affect multiple traits.  Principal component 
analysis (PCA) and factor analysis (FA) both involve a mathematical procedure that transforms a 
number of (possibly) correlated variables into a (smaller) number of uncorrelated (PCA) or 
correlated (FA) variables called principal components or factors. During the PCA/FA extraction, 
the shared variance of a variable is partitioned from its unique variance and error variance to 
reveal the underlying factor / PC structure. Only the shared variance appears in the solution. So it 
is reasonable to believe that these two methods have the potential to classify phenotypic variation 
into independent / dependent components that may amplify or purify genetic signals and hence 
be used to dissect genetic networks regulating complex biological systems.  
Since 2001, ten groups of investigators that we are aware of have published articles that 
used multivariate analysis methods in an attempt to dissect the genetic and environmental basis 
for complex diseases, such as osteoporosis, metabolic syndrome, and asthma.  Seven of these 
groups applied PCA [Chase, et al. 2002; Guo, et al. 2005; Hakulinen, et al. 2006; Karasik, et al. 
2004; Lin, et al. 2005; Musani, et al. 2006; Peacock, et al. 2004], while the other three used FA 
[Austin, et al. 2004; Holberg, et al. 2001; Lee, et al. 2004]. In addition, 7 groups used raw 
phenotypes directly as the input variables, one group used raw traits but performed analysis by 
gender and generation [Karasik, et al. 2004], and the last two groups used residuals (after 
adjustment for significant covariates) [Austin, et al. 2004; Lin, et al. 2005].  The goals of the 10 
groups also differed: one group used multivariate analysis for phenotype 
clustering/classification, by which it developed composite index scores summarizing 
characteristics of raw traits from different skeletal sites [Lee, et al. 2004]. The remaining nine 
groups all focused on exploring the underlying genetic/environmental basis of composite traits 
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(that is, principal components or factors) derived from PCA or FA. Among these nine groups, 
two reported genetic or environmental correlations between composite traits and some well-
defined real (observed) phenotypes [Guo, et al. 2005; Hakulinen, et al. 2006]; two reports 
focused exclusively on heritability estimation for composite and real traits [Austin, et al. 2004; 
Lin, et al. 2005]; and three reports concentrated on the association (or linkage) between these 
composite traits and QTLs (Quantitative Trait Loci) [Holberg, et al. 2001; Musani, et al. 2006; 
Peacock, et al. 2004]; The final two papers did both heritability estimation and 
association/linkage analysis for composite phenotypes [Chase, et al. 2002; Karasik, et al. 2004].  
However, many statistical issues remain unaddressed by these reports. First, the selection 
of either PCA or FA seems arbitrary; none of the groups justified why they chose one instead the 
other. Consequently we decided to evaluate the performance of these two approaches. In 
particular, we wanted to assess which method is better able to detect underlying environmental 
or genetic factors. Second, most reports used raw traits as input variables, but a few used 
residuals after regressing out some important environmental factors. Does analysis of residuals 
significantly improve the ability of PCA or FA methods to detect underlying genetic 
components? No direct comparisons to answer this question have been reported. Third, many 
groups have compared the heritability of composite traits (obtained from PCA or FA) with the 
original phenotypes. Does higher heritability of the composite trait compared to the original 
phenotype necessarily imply that the composite trait better reflects the underlying genetic 
components and thus increase the chance for detecting underlying genes? No literature that we 
are aware of has addressed this question. Hence, the goal of this paper is to explore the answers 
to the above three questions using simulated data on nuclear families. 
 90 
4.2 MATERIALS AND METHODS 
4.2.1 Study Design 
Our overall study design is illustrated in Figure 1. Three datasets of underlying (unobserved) 
traits were generated by simulation; seven underlying traits (E1, E2, G1, G2, G3, S1 and S2) were 
involved in making these three datasets. The differences among these three datasets are the 
variances of the underlying environmental traits and the inclusion or exclusion of S2 (a gene by 
sex interaction phenotype). For each of these three datasets of underlying traits, two sets of 
complex phenotypes were created using arbitrary algebraic functions of the underlying traits. 
There are 50 complex traits in each of the two function sets. Set 1 involves somewhat simpler 
algebraic combinations of traits than set 2 (details below). The seven underlying traits represent 
the unobserved environmental or/and genetic determinants that influence population variation of 
real traits, which are in turn represented by the sets of 50 complex traits. Using these complex 
traits, we created three different inputs for further multivariate analysis: raw traits, residuals 
model 1 (after regressing out E1 and E2); and residuals model 2 (after regressing out E1, E2 and 
sex).  Finally, we performed both PCA and FA on each dataset × function set × residual 
combination, for a total of 36 analyses (Figure 1).  Each aspect of the study design is described in 
more detail below. 
We evaluated three aspects of the outcomes: 1) the ability to detect the underlying 
genetic/environmental components; 2) whether the methods worked better when applied to raw 
traits or to residuals (that is, after regressing out potentially significant environmental 
covariates); and 3) heritabilities of composite traits (principal component or factor) compared to 
50 complex traits or 7 underlying traits.      
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 Figure 8. Blueprint  for study design  (Figure 1 in this chapter) 
 
4.2.2 Simulations 
We first simulated 250 nuclear families with two parents and two offspring within each family. 
We then simulated seven underlying original phenotypes (with corresponding genotypes): E1, E2, 
G1, G2, G3, S1, S2, (Table I) for the offspring only, for a total of 500 individuals. All of these 
underlying traits were assumed to be normally distributed conditional on genotype. The 
simulated “genotypes” for E1 and E2 were not used in the model; these two traits were designed 
as an environmental model (pure environmental effect, no mean differences between people with 
different genotypes).  Because some environmental factors are likely to be similar between 
siblings, we also allowed for the effect of a shared common environment for E1 and E2 by 
simulating these two traits based on a bivariate normal distribution with means all equal 1, 
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standard deviation equals 1 or ½ for different datasets and covariance between two sibs equals to 
0.2 for E1 and 0.1 for E2. Another three traits (G1, G2 and G3) are standard simple genetic models 
in which means differences among genotypes. As can be seen in Table I, the genotypic means 
and error variances for, G1, G2 and G3 are identical (mean 1.5, 2.5 and 3.5 for genotype aa, Aa 
and AA respectively and all standard deviations = ½); only the allele frequencies of these traits 
differ. The trait S1 has different means for males and females, but no interaction between sex and 
genotype. The trait S2 incorporates sex by genotype interaction.  
 
Table 16. Simulation parameters for 7 Underlying Phenotypes 
(Table 1 in this Chapter) 
 
4.2.3 Complex Traits 
Based on the above underlying traits, we created the first set of 50 complex traits, each of which 
is an algebraic combination of a subset of the 7 unobserved traits plus the error term, which is 
normally distributed with mean 1 and standard deviation 1 (table II). Our objective in choosing 
these functions was to reflect the current genetic/epidemiological assumptions about complex 
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traits regarding the effects of underlying immeasurable genetic / environment factors. For 
example, we used additive and multiplicative effects as well as their combinations within and/or 
between underlying genetic and environmental traits. In addition, we included several very 
complicated models to assess if PCA and FA could recover underlying traits even from 
extremely complex traits.  In order to assess even more complex models, we then created 
another set of 50 complex traits, in which we removed some of the algebraically simpler 
combinations and substituted more complex ones. These new 50 functions were similar in format 
to the more complicated ones in the first set of functions (Table III). When devising our 50 
complex traits for each set, we required that each underlying trait have a similar representation 
across all 50 complex traits. Based on our function summary file for dataset 1 and 2 (Tables II 
and III), the percent of times a specific underlying variable (e.g. G1) was included in the 
definition of a complex trait across all complex traits was as follows: 60% for E1, 54% for E2, 
58% for G1, 54% for G2, 56% for G3 and 58% for S1. In dataset 3, we simply substituted S1 for 
G3 and S2 for S1, so the proportions are the same.  
These complex traits represent phenotypes that we could observe or directly measure in 
reality, such as bone mineral density (BMD), body mass index (BMI), glucose level, and blood 
pressure. The seven original traits represent underlying genetic or environmental components; 
they contribute to the true variation of the measured (complex) traits but are not actually 





For each set of functions (Table II and III), we created three different datasets of underlying  
 
Table 17. First Set of 50 Complex Traits 





 traits by simulation to evaluate the performance of the multivariate analysis methods. Datasets 1 
and 2 use only 6 out of 7 underlying traits: E1, E2, G1, G2, G3, and S1 (see Tables II, III and 
Figure 1). The only differences between these two datasets are is the standard deviations of E1 
and E2 as is described above. For the third dataset, we substituted underlying traits S1 for G3 and 
S2 for S1. However, we kept the functions the same and set the standard deviation equal ½ for E1 
and E2.   Take trait C49 in the second set of functions as an example. We used 
4.2 / [log (2S1 + 2G3 - E1 + 2) -3] + error 
for dataset 1 and 2, and  
4.2 / [log (2S2 + 2 S1 - E1 + 2) -3] + error 




Table 18. Second Set of 50 Complex Traits 





 We designed these three datasets to perform the following comparisons. 1) By comparing 
analysis results from datasets 1 and 2, we could assess the behavior of the two multivariate 
analysis methods behave when trait variation due to environment decreases; or in other words, 
when the proportion of total phenotypic variance due to genetics increases. 2) By comparing 
analysis results from datasets 2 and 3, we could evaluate the behavior of the analysis methods 
with and without the presence of sex by genotype interaction.  (Figure 1) For simplicity, we will 
refer to datasets 1, 2 and 3 in the subsequent text as the high-environment dataset, the low-
environment dataset, and the gene by sex interaction dataset, respectively. 
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Table 18 continued
4.2.5 Statistical Analysis 
The input variables for the multivariate analyses were either 50 complex traits in their original 
form (raw traits) or residuals of these traits (after removing the linear effect of covariates). Two 
types of residuals were analyzed: 1) residuals after adjusting for E1 and E2; or 2) residuals after 
adjusting for E1, E2 and sex. Both sets of residuals were derived from each of the 50 continuous 
traits by multiple regression after the incorporation of corresponding covariates. To mimic 
analysis methods that would be used in a real study, we only considered the linear form of 
covariates in the multiple regression, although quadratic and other non-linear effects of E1 and E2 
are included in our arbitrary functions.  
The Pearson pairwise correlations among all 50 complex traits (or residuals) were 
estimated using the R statistical package (V2.4.0 for windows) [Guo, et al. 2005]. Principal 
component analysis and factor analysis were both performed in R using its standard default 
procedure (varimax rotation, correlation matrix use Pearson) with all default options 
(Commands: princomp and factanal).  For simplicity, we performed comparisons using only the 
first PC or factor, which explains the largest proportion of variation across 50 complex traits. 
The derived PCs or factors will be referred to as composite traits below.  
4.2.6 Evaluation 
Two evaluation strategies were applied. First, we evaluated the ability of each method to detect 
common underlying environment or genetic components. We performed univariate regression 
analyses and regressed every underlying trait on the first composite trait (PC or factor). 
Correlations (R2) between each composite trait and each underlying original trait were estimated. 
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Second, for each trial, we estimated heritabilities for all phenotypes, including the 7 underlying 
traits, the 50 complex traits and the two composite traits (first principal component and first 
factor). Box plots were used to show how heritabilities of 50 complex traits spread. And the 
heritability estimate for each composite trait was marked on the corresponding box plot. The 
estimated heritability of a trait using data on full-sibs was calculated as: H2 = 2 × (trait 
correlation between sibs) [Beck, et al. 1998].  
4.3 RESULTS 
4.3.1 Analysis of Correlations 
Tables IV and V summarize all correlations (R2 from univariate regression) between composite 
traits and each underlying phenotype.  Although we generated three independent replicates for 
each of our 36 dataset/analysis combinations, the results were similar. Thus we report here the 
results from one replicate (Tables IV and V). 
Overall, both multivariate analysis methods (FA and PCA) show similar correlation 
patterns between composite trait and underlying trait with very few exceptions. When the trait 
models are more complicated (traits derived from the function set 2) and analyses are performed 
on residuals, these two methods appear to detect different underlying traits. For example, FA was 
most highly correlated with underlying trait S1, whereas PCA was correlated with trait G1 in the 
analyses of the second function set, low environment dataset, and using residuals after regressing 
out E1, E2 or E1, E2 and Sex (Table V).  
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Table 19. Correlations between Composite Trait and Underlying Phenotype in Function set 1 
(Table 4 in this Chapter) 
 
 
However, even in those cases in which both methods display qualitatively similar results, 
we think factor analysis demonstrates a stronger ability to detect predominant signals from 
underlying traits than PCA, by which it may benefit the downstream QTL analysis. We found 
that when composite traits from both methods show significant correlations to a specific 
underlying trait, the correlation coefficient (R2) between the first factor and that underlying trait 
is substantially higher than the corresponding correlation of the first principal component and the 
underlying trait. For example, in the first set of functions, high environment dataset, and 
residuals after adjustment of E1 and E2 model, correlations between S1 and the first factor from 
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FA and the correlation between S1 and the first principal component from PCA are 0.88 and 0.68 
respectively. 
Table 20. Correlations between Composite Trait and Underlying Phenotype in Function set 2 
(Table 5 in this Chapter) 
 
We also compared results of multivariate analyses performed using raw complex traits 
versus residuals of the complex traits. As can be seen (Tables IV and V), PCA or FA analysis of 
residuals greatly improved detection of common genetic components instead of common 
environmental factors. For example, instead of picking up E1 for both high and low environment 
datasets when using raw traits from either function set 1 or 2, factors or PCs detected one of the 
underlying genetic components. Both PCA and FA obtained the highest correlation with 
underlying trait S1 for both datasets using residuals after regressing out E1 and E2. Furthermore, 
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the correlation between the environmental traits (E1 and E2) and the composite traits derived 
from the residuals is zero.  As stated in the methods, we only regressed out the linear effects of 
E1 and E2 on the complex traits, even though the complex traits are in fact non-linear functions of 
E1 and E2. Our limited results suggest that performing a linear regression of environmental 
factors may be effective in removing some of the non-linear effects from environmental 
correlates. However, these results might depend on the specific set of non-linear functions we 
used and thus further evaluation is needed.    
Finally, our results indicate that removing the effects of a covariate (i.e., sex, in our 
example) that has an interaction effect with the genotype on an underlying trait (i.e., trait S2), 
substantially decreases the potency of PCA or FA for detecting this underlying trait.  This is 
indicated in the second residual model (after adjusting for E1, E2 and sex) for both sets of 
functions in Tables IV and V.  
4.3.2 Analyses of Heritabilities 
We next compared the heritability of the underlying (unobserved) traits, the complex (observed) 
traits, and the first principal components from PCA and the first factor from FA. Figure 2 shows 
the boxplot of heritabilities for 50 complex traits compared with estimated heritabilities for the 
composite traits. Table VI lists mean heritabilities (or twice the sibling resemblance for non-
genetic traits like E1 and E2) and the corresponding ranges for underlying traits. All mean 
heritabilities were calculated after taking the average of heritabilities from three replicates and 
the range shows the variations of heritabilities among replicates. As indicated by Figure 2, there 
is no predictable relationship between the heritability of the composite traits and the heritability 
of 50 complex traits. In other words, in contrast to our expectations, the heritabilities of the 
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composite traits are not necessarily higher or lower than those of the original traits. We expected 
that the heritabilities of composite traits would be higher than those of the 50 complex traits, 
because multivariate analysis would incorporate co-variations for multiple traits due to shared 
genetic factors (pleiotropy), especially after removing environmental factors via regression 
analysis.  
However, further comparisons of the heritabilities for composite traits and underlying 
phenotypes (Table VI), indicates that heritabilities of PCs and factors FA and PCA were 
consistent with the underlying model. In other words, the genetic and environmental information 
embedded in the composite trait reflects the genetic and environmental signals from underlying 
traits which had the highest correlations with the composite traits. For example, in function set 1, 
high environment dataset, using the raw trait model, the FA composite trait seems to be 
exclusively coming from E1 (correlation = 0.90) (Table IV). The heritability (or in this case, 
twice the sibling correlation) for this composite trait and heritability of E1 are comparable (0.454 
vs. 0.47). For the same function and dataset, but using the first residual model (adjusting for E1 
and E2), the FA composite trait captured information mostly from S1.  The corresponding 
heritabilities of first factor and S1 are also comparable (0.265 vs. 0.30).    
4.4 DISCUSSION 
There are several interesting and useful conclusions based on our study. The seven underlying 
traits that we simulated are intended to be representative of the unobserved environmental or/and 
genetic determinants which influence population variation of real traits. Likewise, the sets of 50 
complex traits derived from these 7 original phenotypes reflect potentially real phenotypes that  
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 Figure 9. Heritability Estimation of Composite and 50 Complex Traits (Figure 2 in this chapter) 
Footnote for Figure 9  
 
* F1-D1: first set of functions, dataset 1; F1-D2: first set of functions, dataset 2; F1-D3: first set of functions,  
  dataset 3; F2-D1: second set of functions, dataset  1; F2-D2: second set of functions, dataset 2; F2-D3: second  
  set of functions, dataset 3.  
      
PC: first principal component from PCA with raw trait model; PCR1: first principal component from PCA  
with residual model 1 (after regressing out E1 and E2); PCR2: first principal component from PCA with  
residual model 2 (after regressing out E1, E2 and Sex)  
                
FA: first principal component from Factor Analysis with raw trait model; FA1: first principal component from  
Factor Analysis with residual model 1 (after regressing out E1 and E2); FA2: first principal component from  
Factor Analysis with residual model 2 (after regressing out E1, E2 and Sex) 
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could be directly measured. Thus, any statistical analysis that can successfully identify variation 
attributable to any underlying original trait should theoretically have better power to detect genes 
when used in a genetic linkage or association analysis. As indicated by our results, factor 
analysis seems to perform better than PC analysis. This conclusion is based on the higher 
correlation between factors and the most significant underlying traits(whichever shows the 
highest correlation coefficient) compared to that of PCs and the underlying traits.  In a real world 
analysis, a higher correlation between a composite trait and an underlying phenotype (if it is due 
to genetics), should increase the probability of detecting and identifying the underlying genes. 
Hence, we would recommend factor analysis rather than principal component analysis. Another 
reason we prefer FA, although not discussed in the results, is that PCA assumes an orthogonal 
relationship between its PCs, while FA does not. The assumption of independent extracted 
components may conflict with the true genetic model. For example, bone scientists hypothesize  
  
Table 21. Mean Heritability (Sibling Resemblance) Estimation for Underlying Traits   
(Table 6 in this Chapter) 
 
 
that genes influencing bone size may differ from genes influencing for bone mineral density 
(BMD) (82,83). However these two sets of genes might interact with each other. If we put 
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several bone size and BMD traits together into PCA, it is almost impossible to generate two 
independent PCs which represent both the set of the bone size genes and BMD genes 
respectively.  
Another conclusion from these analyses concerns the use of residuals versus raw trait 
values in multivariate analysis. Our results indicate that regressing out potentially significant 
environmental covariates should greatly increase the chances for detecting genetic components 
using both FA and PCA, but that if the underlying trait exhibits a genotype by environment 
interaction (see the results of our analyses with sex), removing the linear effects of such 
environmental covariates, in some cases, could decrease or even remove the genetic signal from 
the composite trait. This result has two different practical implications for real studies. First, any 
covariate that is not observed obviously cannot be regressed out, so one must be aware when 
applying FA or PCA that the factors/components that are identified could represent underlying 
environmental factors rather than underlying genetic factors. Second, our result actually suggests 
that for observed covariates, regressing them out might not be the best strategy. If known 
covariates are not regressed out, derived factors or components may be highly correlated with 
them, but precisely because the covariates are observed, we can check our results for such 
correlations and ignore those factors. For example, if one were to perform PCA or FA on a set of 
traits that reflect physical size (e.g. height, weight, various bone lengths) without regressing out 
sex, one would undoubtedly discover that the first component was very highly correlated with 
sex. One could then ignore that component and go on to look at the second one, secure (one 




Our conclusions regarding heritability are somewhat counter to the conventional 
assumption that using multivariate analysis can and should increase trait heritabilities. As shown 
in the results, the heritability for composite traits is not necessarily higher than that of the 
original complex traits. However, high trait heritability does not necessarily predict successful 
detection of genes by linkage or association analysis, because what really matters is the 
heritability attributable to any single locus. Thus the success in detecting relevant genes depends 
not only on the number of loci influencing a trait, but also on the relative contribution of each 
locus.  In our analysis, we observed some examples of this phenomenon. For example, in the first 
set of functions, low environment dataset, using residuals adjusting for E1 and E2, the 
heritabilities for the traits derived using both FA and PCA are relatively low (0.20 and 0.18 
respectively). However, both composite traits are highly correlated with underlying trait S1, 
which also has a heritability of 0.18. These composite traits should be more useful for 
downstream gene hunting than any of the individual complex traits precisely because their 
heritability only reflects a single underlying locus and is not inflated by contributions from other 
loci or environmental correlation.     
Certain limitations of this study need to be acknowledged. One of the most important is 
that in a real study one would want to identify more than just one factor or principal component, 
so the performance of the methods to detect more than one meaningful component should be 
tested in the future. Another critical issue is that in order to compare methods more conclusively 
it would be desirable to simulate genetic markers and conduct linkage and/or association studies 
so that the bottom-line success rates of the methods can be quantified. Finally, the effect of 
sample size on our results should be studied. We simulated 250 families, or 500 sibs with 
phenotypic data, which is comparable to real datasets to which these methods have been applied. 
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It is clear from our results that the relatively small sample size does not produce very stable 
estimates of heritabilities, because we got widely varying heritability estimates across our three 
replicates of each dataset (Table VI). However, our bottom-line results – correlations between 
the underlying traits and the composite traits – were quite stable across replicates, giving us 
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5.0   MULTIVARIATE ANALYSIS OF BONE QUALITY RELATED PHENOTYPES 
FROM THE TOBAGO FAMILY STIDY 
5.1 INTRODUCTION 
Studies over the past several decades have well documented the major genetic contributions to 
osteoporosis as well as the bone strength related traits. Most of these bone strength related traits 
are shown to be moderately to highly heritable (1), which were reflected by the higher heritabilies 
compared to other complex disease phenotypes such as blood pressure, glucose level. Despite the 
fact that evidence for linkage with some of the bone phenotypes was observed in the recent 
years, many studies suggested that some of the bone strength related traits are governed by 
common sets of genes (e.g. pleiotropy) (104-111). The evidence in favor of the above hypothesis is 
that bivariate linkage analyses revealed new or stronger linkage signals were found for many of 
the bone traits compared with the univariate linkage results (112). Because conventional 
measurements of the bone strength phenotypes produce many intercorrelated phenotypes, it is 
possible that there might be a relatively small number of factors (both genetic and 
environmental) involved in bone and mineral metabolism that contribute to an underlying 
clustering of bone strength phenotypes. Identification of these common factors and elucidation of 
their molecular basis will contribute to a better understanding and possible treatment for 
osteoporosis. 
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 Multivariate analysis (PCA /Factor analysis) might be one of the effective solutions to the 
above questions. PCA / Factor analysis (FA) involves a mathematical procedure that transforms 
a number of (possibly) correlated variables into a (smaller) number of uncorrelated (PCA) or 
correlated (Factor) variables called principal components or factors. During the factor / PC 
extraction, the shared variance of a variable is partitioned from its unique variance and error 
variance to reveal the underlying factor / PC structure. Only the shared variance appears in the 
solution. So it is reasonable to believe that these two methods have potential to classify 
phenotypic variation into independent / dependent components that may amplify the genetic 
signal and hence be used to dissect genetic networks regulating complex biological systems. 
The Tobago family study comprises data on both phenotypic (different bone 
measurement by DXA and pQCT) and environmental factors (including life style, diet, diseases 
status etc.) on 471 individuals aged 18 and older (mean, 43 years) from 8 large, 
multigenerational Afro-Caribbean families with a mean family size >50 individuals (range from 
21 to 112). Using the up-to-date technology (Dual X-ray Absorptiometry, DXA and Peripheral 
Quantitative Computed Tomography, pQCT), we measured more than 100 different bone 
strength related phenotypes from our participants. Among those traits, more than 50 phenotypes 
are widely studied and well accepted in the bone research field.  
All these phenotypes were measured quantitatively (continuous traits). Most of traits are 
normally distributed; although a few traits are highly skewed (for example, endo-cortical 
thickness at radius shaft) and other traits (some bone stress strain index traits) demonstrate a 
bimodal distribution due to the significant gender differences. Many of the phenotypes are 
correlated each other due to underlying biologtical influences or mathematical construction.  For 
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example: BMD (Bone Mineral Density) traits were calculated from the corresponding BMC 
(Bone Mineral Content) traits (BMD =BMC / area) and total density is approximately the sum of 
cortical and trabecular density. Composite traits like SSI (Stress Strain Index) are derived from 
bone area, bone circumference and BMD, so it may reflect the co-distribution of those raw traits.  
In this study, we develop composite traits by PCA or FA, which subsequently could be 
used in the downstream association studies.  Initially, 12 different BMD phenotypes measured by 
either DXA or QCT were used to further evaluate these two multivariate methods.  We were 
particularly interested to see how these 12 traits would be classified / clustered by multivariate 
analysis, that is, did the clustering of the original phenotypes correspond with known biological 
expectations. In addition, as described in the next chapter, we perform association studies using 
these composite traits to determine whether the composite traits reveal stronger genetic signals 
(reflecting a true positive association between SNPs and trait) with more power when compared 
to a “one trait at a time” strategy. 
5.2 MATERIALS AND METHODS 
5.2.1 Study Phenotypes 
Twelve BMD related phenotypes were analyzed in this section: 1) four traits measured by 2-
dimensional DXA, including: total BMD at whole body (WBTOTBMD), total Spine BMD 
(STOTBMD), femoral neck BMD (NECKBMD) and total hip BMD (HTOTBMD); and 2) eight 
traits measured by 3-dimensional pQCT, including: total density at distal radius and tibia 
(TOTDENr4 and TOTDENt4), trabecular density at distal radius and tibia (TRABDENr4 and 
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TRABDENt4), total density at radius and tibia shaft (TOTDENr33 and TOTDENt33), cortical 
density at radius and tibia shaft (CRTDENr33 and CRTDENt33).   
5.2.2 Statistical Analysis 
Prior to performing multivariate analyses, we assessed the distributions of all traits, and 
transformed traits if necessary to reduce non-normality (state which ones you transformed and 
why). In addition, outliers (observations beyond ±4SD) were removed for each BMD trait and 
no more than 4 four values were removed for a single variable. For the subsequent multivariate 
analyses, we analyzed both (1) the 12 original raw BMD traits, and (2) residuals of the 12 traits, 
after regressing out the significant covariates (refer to Chapter II, table 4). Due to the different 
measurement scaling units used by DXA and pQCT, we then standardized the distribution for 
each (raw or residual) trait, i.e., all traits had mean = 0 and SD = 1.   PCA and factor analysis 
were performed using the default option (varimax rotation, correlation matrix use Pearson for 
commands princomp and factanal) in the R statistical package R (V 2.4.1) (113).  We also ignored 
the family relationship among individuals within each pedigree when deriving the composite 
PCA and FA traits. For simplicity, we will refer in the following text those composite traits 
which were derived by multivariate analysis using 12 original BMD traits as composite (raw) 
and similarly those using residuals as composite (residual).      
After performing multivariate analysis, we estimated the residual heritabilities (H2r) of 
all 38 composite traits (12 PCs and 7 factors in both raw and residual model), using SOLAR (114) 
and compared these results with the H2r of the 12 original BMD traits. Residual heritabilities of 
the 12 original BMD traits and composite(raw) traits , were estimated after including age, sex, 
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weight and height as covariates. Heritability of the composite (residual) traits had already been 
adjusted for sex, weight, and height, and there were no additional effects of these covariates.  
5.3 RESULTS 
5.3.1 Multivariate Analysis 
The proportion of variance and PCA loadings  for PC (raw) and PC (residual) traits are 
summarized in tables 1 and 2, respectively. In most cases, the characteristics of PCs derived from 
raw or residual traits are qualitatively similar. For example, PC1(raw) and PC1(residual)  
accounted for approximately half of total phenotypic variation from 12 original BMD traits, and 
the first 4 PCs (raw or residual) accounted for ~80% of total phenotypic variation.  More 
importantly, the loadings (table 2) of each PC for raw and residual groups are comparable to 
each other. As can be seen, PC2(raw) and PC2(residual) contain higher loadings for 4 
predominantly cortical traits (TOTDENr33, CRTDENr33, TOTDENt33, CRTDENt33) which 
may indicate a common environment or/and shared genetic impact on these traits. Similarly, 
higher loadings of 3 or 4 predominantly trabecular traits (TOTDENr4, TRABDENr4, 
TOTDENt4，TRABDENt4) were observed in PC8(raw) and PC8(residual) for both groups. 
Finally, both PC10 (raw) and PC10 (residual) had higher loadings for most of the pQCT 
measured phenotypes plus the DXA whole body BMD.      
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Table 22. Proportion of Variance of Principal Components in Raw and Residual Models 
(Table 1 in this Chapter) 
 
 
The factors derived from raw or residual traits differed more than the PC described 
above. First, the proportions of variances attributable to each factor (raw) differed from that for 
each factor (residual). For example, the first 3 factors (raw) accounted for ~60% of original total 
phenotypic variation of 12 raw traits, of the first 3 factors (residual) explained ~40%. Second, the 
factor (raw) and factor (residual) loadings appear to reflect different aspects of underlying 
skeletal biology. For example, factor2 (raw) comprised higher loadings for 4 DXA BMD traits. 
However, factor2 (residual) is comprised of traits related to predominantly cortical bone 
(TOTDENr33, CRTDENr33, TOTDENt33, and CRTDENt33). Third, from table 5, total spine 
BMD, trabecular BMD at distal radius, and total density at radius shaft were poorly represented 
(uniqueness >20%) by factors (raw), whereas total spine BMD, total density at both distal radius 
and tibia plus total density at radius shaft were poorly represented by factors (residual). 
When we compared results across both multivariate methods, we observed two major 
differences. First, compared to PCs, each of factors accounted for substantially smaller 
proportion of original phenotypic variation from 12 BMD phenotypes (see Tables 1 and 3).  
Second, the loadings of PC (raw) and PC (residual)  did not differ, but factor (raw) and (factor 
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(residual) did. In addition to these two major differences, there is another subtle, though 
important, difference between PCA and FA. Based on our current knowledge of the underlying  
 
Table 23. PCA Loadings in Raw and Residual Model 
(Table 2 in this Chapter) 
 
 
biology of the 12 original traits, we believe factor analysis is more successful in 
grouping/clustering the traits into composite traits than is PCA.  For example, factor analysis, 
factor2 (raw) was more correlated to four DXA phenotypes (higher loadings for these traits); 
factors 3, 5 and 7 (raw) represented several cortical phenotypes; and factor4 (raw) was more 
representative of trabecular traits. A similar pattern is evident in the factors (residual) (table 4). 
However, in PCA analysis, the composition loadings for most of PCs did not cluster based on 
our current understanding of bone biology (table 2). 
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5.3.2 Heritability Estimation of Composite Traits 
Table 6 shows the residual heritability (after adjustment for age, sex, height and weight) for 12 
original BMD traits. Table 7 summarizes the same residual heritability for PCs and factors for 
both raw and residual trait groups. Several conclusions can be made from these results.  First, 
similar to our simulation results (Chapter IV using simulation data (115)), there was no predictable 
relationship between the heritabilities  
 
Table 24. Proportion of Variance for Factors in Raw and Residual Model 
(Table 3 in this Chapter) 
 
 
of composite traits and heritabilities of original phenotypes. In other words, the heritabilities of 
composite traits were not necessarily higher, equal or lower than the original phenotypes. In 
addition, the residual heritability estimates of composite traits were close to each other if they 
represented (had higher loadings for) similar underlying original traits. For example, PC8 (raw 
and residual) (table 2) were both more associated (higher loadings) with some or all of the 
original traits reflecting trabecular density (trabecular density and total density at distal radius / 
tibia). The H2r for these two composite traits were 0.47±0.11 to 0.47±0.12 respectively. 
Similarly factor3 (residual) and factor4 (raw) both reflect trabecular density, and H2r is 
0.46±0.14 and 0.43±0.11 respectively). In addition, factor 2 (residual) and factor 3 (raw) both 
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reflect cortical density traits,  and H2r equals 0.27±0.09 and 0.15±0.10 respectively. Finally, we 
reported in our  
Table 25. Factor Loadings in Raw and Residual Model  
(Table 4 in this Chapter) 
 
previous study that the H2r for trabecular BMD traits are higher than those of cortical BMD 
traits (1). And we also observe a similar result for the composite traits.  The residual heritability 
for composite traits with high loadings for the original trabecular BMD traits, e.g., PC8 (raw and 
residual), factor (raw), factor3 (residual)  
Table 26. Uniqueness of Variance for Factors in Raw and Residual Model 




 and factor5 (residual), ranges from 0.43±0.11 to 0.64±0.12.  On the other hand, heritabilities for 
composite traits corresponding to cortical bone phenotypes, e.g. PC2 (raw and residual), PC10 
(raw and residual), factor3 (raw), factor7 (raw) and factor2 (residual), range from 0.15±0.10 to 




Table 27. Heritability Estimation for 12 original BMD phenotypes 




Table 28. Residual Heritability Estimation for Composite Traits (Raw and Residual) 




 5.4 CONCLUSION 
In summary, we derived composite traits from data on 12 bone-strength related phenotypes using 
two multivariate analysis methods: principal component analysis and factor analysis. PCs and 
factors were derived using both raw phenotype data, as well as residual phenotypes obtained 
after adjusting for significant covariates.  We found that PCA and Factor analysis behave 
qualitatively similar for both raw and residual models, although the similarity in results is higher 
for PCA than FA. We believe factor analysis is more successful in grouping/clustering original 
BMD phenotypes into composite traits than PCA, because the individual factors comprise 
clusters that more accurately reflect our current knowledge of bone biology. We also observed 
there was no predictable relationship between the heritabilities of composite traits and 
heritabilities of original phenotypes, most likely because the composite traits were comprised of 
multiple underlying traits, each of them with its own different heritability. However, if the 
composite traits reflected similar underlying traits, their heritabilities were similar. More 
important, similar to our previous report, the residual heritabilities for more trabecular related 
composite traits are substantially higher than those of more cortical related composite traits. 
We note that the multivariate analyses were performed ignoring the non-independence of 
our sample observations, however, we do not expect this violation to seriously affect our results.  
First, our results are comparable to those of other investigators, because investigators usually 
ignore family relationship when performing PCA or FA, most likely because methods that 
incorporate dependencies are not available. Second, we do not think a violation of this 
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assumption will cause significant deviations from true model. For example, our conclusion 
agrees perfectly with our previous findings that the residual heritabilities of trabecular related 
traits were substantially higher than those for cortical ones, even though here we talked about 
composite phenotypes instead of original traits. 
Finally, we note that the current evaluation of two multivariate methods in Chapter IV 
and V are based on quantitative genetic results and our current assumptions regarding bone 
biology.  We have not assessed whether use of these methods will facilitate detection and 
identification of specific polymorphisms that influence bone traits.   However, we will further 
assess the PCA and FA methods as part of our association analyses described in Chapter VI.     
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6.0  ASSOCIATION OF BONE QUALITY PHENOTYPES WITH WNT10B AND 
ENPP1 SNPS: THE TOBAGO FAMILY HEALTH STUDY 
6.1 INTRODUCTION 
Genetic susceptibility plays a predominant but poorly understood role in the etiology of 
osteoporosis and its associated fractures. (116-119) A genetic component to osteoporosis is 
supported by the strong heritability (60-80%) of bone mineral density (120) and bone structural 
geometry (121-123) and the increased risk of osteoporotic fractures among first-degree relatives 
with a positive family history of fracture. (9) Identifying the genetic factors underlying normal 
variation in BMD and skeletal geometry may therefore provide important insight on bone 
biology and osteoporosis. 
Several groups have conducted genome-wide scans to search for quantitative trait loci 
(QTL) influencing BMD (125-127) and bone geometry. (128-130) These studies have implicated QTLs 
on several chromosomes, but the specific genes at these chromosomal sites have not been 
identified.  
More recent studies have drawn our attentions to two genes: Wnt10b (one of 19 genes in 
wingless-type (WNT) family) and ENPP1 (ectonucleotide pyrophosphatase / phosphodiesterase 
1). Wnt10b has been shown to stimulate osteoblastogenesis thereby increasing bone mass in 
vitro. (131-134) Transgenic mice over-expressing Wnt10b have 4 times greater bone mass and are 
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protected from bone loss due to estrogen-deficiency.  In contrast, Wnt10b knock-out mice have 
decreased trabecular bone compared to wildtype mice. (132) All these studies collectively 
implicate the Wnt signaling pathway as having a major role in skeletal biology and bone health. 
The ENPP1 enzyme regulates soft-tissue calcification and bone mineralization by generating 
inorganic pyrophosphate (PPi), a solute that triggers cell differentiation and serves as an essential 
physiological inhibitor of hydroxyapatite deposition. (135, 136) The phenotypic consequences of 
ENPP1 mutations in men and mice suggest that genetic variability of ENPP1 activity may 
contribute to common forms of articular disorders, such as osteoarthritis. (137)  
In this section, we present our genetic association results from Tobago family study 
between polymorphisms in the Wnt10b and ENPP1 loci and several bone phenotypes include 
bone mineral density (areal and volumetric BMD) and skeletal geometry traits. We also compare 
results of single trait analyses versus analyses of composite traits derived from PCA and FA to 
determine whether multivariate analyses resulted in more and stronger association signals. 
6.2 MATERIALS AND METHODS 
6.2.1 Study Samples 
SNP associations for WNT10b and ENPP1 in Tobago Family analysis used DNA samples and 
phenotypic data collected in the Tobago Family Health Study (5). To be eligible, a proband must 
have been Afro-Caribbean, have a spouse who was willing to participate in the study, and have at 
least six living offspring and/or siblings aged 18+ years residing on the island of Tobago.  
Potential probands were sorted by family size, and individuals with the largest family sizes were 
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recruited first.  Probands were recruited regardless of health status.  All eight probands were 
between 52-103 years of age. In addition, all first-, second- and third-degree relatives of these 
probands and their spouses were invited to participate regardless of their medical history or 
BMD. To date, we have recruited 471 individuals age 18 and older in eight multigenerational 
families with a mean family size of >50 individuals. These 284 women and 187 men with 
phenotype data ranged in age from 18-103 years (mean age, 43 years). There are a total of more 
than 3,535 different relationship pairs ascertained. Written informed consent was obtained using 
forms approved by the Institutional Review Boards of the University of Pittsburgh and the 
Tobago Ministry of Health.  
6.2.2 Skeletal Measurements 
BMD phenotypes: Total body DXA was used to assess bone mineral density at the whole body, 
total hip, femoral neck, lumbar spine using the array beam mode on a Hologic QDR 4500W 
scanner (Hologic, Bedford, MA, USA). All pQCT measures were performed using a Stratec 
XCT 2000 scanner (Stratec Medizintechnik, Pforzheim, Germany) on the nondominant forearm 
and left tibia according to standardized measurement and analysis procedures. (120) Measures of 
volumetric BMD included: total BMD and trabecular BMD at distal radius and tibia; total BMD 
and cortical BMD  at radius and tibia shaft.  
Bone geometry phenotypes:  A variety of bone geometry traits were also obtained using the array 
beam mode on a Hologic QDR 4500W scanner. Each scan was acquired with a 0.5-mm voxel 
size, slice thickness of 2.5 mm, and at a speed of 20 mm/s. The precise position of the 
measurement sites were determined in a 30 mm planar scout view using the medial endplate of 
the radius and tibia as standard anatomic landmarks and automatically set by the software at 33% 
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(i.e. shaft) of the length of the radius and tibia proximal to the distal endplate. These anatomical 
sites were chosen in order to assess primarily cortical bone. Tibia length was measured from the 
medial malleolus to the medial condyle of the tibia, and forearm length was measured from the 
olecranon to the ulna styloid process. Image processing was performed using the Stratec software 
package (Version 5.5E).  All 33% proximal radius and tibia shaft scans were analyzed using 
identical parameters for contour finding and separation of total and cortical bone (contour mode 
2, T=169 mg/cm3;cortmode 1, T=710 mg/cm3). Endosteal and periosteal circumference (ENDOC 
and PERIC), and cortical thickness (CRTTHKC, mm) were measured using a scan through the 
diaphysis (at 33% of the bone length in the proximal direction of the distal end of the bone) of the 
radius and tibia using the circular ring model (138, 139).  
6.2.3 Selection of SNPs 
My colleagues found previously in the Tobago population project (genotyped 1653 men, age 40 
and above, mean age =59 yrs) that there were significant associations between the 
polymorphisms of several SNPs in these two genes (WNT10b and ENPP1) and some of the bone 
phenotypes (Laura Yerges, unpublished results). Thus, we were interested to see if we could 
replicate these signals in our Tobago family dataset.  
In our Tobago family study, there are only 4 SNPs available for both genes: 3 SNPs were 
genotyped for WNT10b and 1 SNP for ENPP1. Among those 3 WNT10b SNPS, two of them 
(WNT_1886, rs1051886 and WNT_1627, rs3741627) were predicted to tag each other in the 
previous population study by HCLUST (140). Additional one SNP (WNT_5902, rs10875902) was 
included on the 3’ end of the gene in order to better define the association signal.  We genotyped 
only one SNP (ENPP1_4988, rs1044498) in the family study. This SNP is a missense 
 127 
polymorphism, responsible for Lys121Gln substitution), which was well reported previously that 
the Gln121 is associated with insulin resistance, type 2 diabetes and both cardiovascular and 
nephrovascular complications in diabetes patients. (141)    
6.2.4 Statistical Analysis 
We assessed the skewness, kurtosis, and distributions for all traits. No transformation was 
needed for traits we used in association analysis. Outliers (observations beyond ±4SD) were 
removed for each BMD trait and no more than 4 four values were removed for a single variable. 
Single SNP association analyses were performed using, maximum likelihood methods 
(SOLAR (V2.1.4), which allowed the incorporation of familial relationships.   
We tested whether the SNP genotypes displayed a linear (additive) effect on the traits 
(code SNP genotypes as 0, 1, 2 and they stand for common homozygotes, heterozygotes and rare 
homozygotes respectively).  We also tested for dominant or recessive effect on traits (code SNP 
using two dummy variables). We performed association studies between four available SNPs and 
more than thirty different bone phenotypes (including DXA and pQCT measured BMD and bone 
size related traits). Age, sex, height and weight, the four most important predictors for bone 
phenotypes reported by previous studies (120), were included in our analysis model as covariates. 
We compared our results from Tobago family analyses with the previous findings from Tobago 
population based project and MrOS data (Osteoporotic Fractures in Men). Because the main 
purpose of these analyses was to try to replicate results from the population study, we report 





Based on 88 unrelated individuals in our family data, the linkage disequilibrium (LD) between 
WNT1886 and WNT1627 is very high (r2 = 0.9), whereas LD between either of these two SNPs 
and WNT5902 is comparatively lower (r2=0.82). And this is true in Tobago population data 
(Figure 1, unpublished results from S. Moffett). Thus, we decided not to include association 
results for WNT1627 below, because the genetic information in WNT1886 and WNT1627 is 
almost identical. 
We also estimated the allele frequencies for each SNP in family data. The minor allele 
frequencies for WNT1886, WNT5902 and ENPP1_4498 are 0.14, 0.14 and 0.12 respectively. 
There were no obvious departures from HWE observed based on 88 unrelated individuals in our 
Tobago family data. 
 
Figure 10. LD for genotyped SNPs in Wnt10B in Tobago Population Study  
using Haploview GOLD plot (Figure 1 in this chapter) 
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 6.3.1 Association with Areal and Volumetric BMD and Bone Size Traits 
Tables 1 and 2 summarized the positive association signals from the Tobago family study 
between bone phenotypes and each of the SNPs. For each SNP, the adjusted genotype-specific 
mean, standard error, sample size, and nominal p-value in family study. We also provided the 
corresponding nominal P value from the population-based analyses (for table 1 only. S. Moffet 
and L. Yerges, unpublished results).   
  
Table 29. Genotype Specific Means and P value for association study for WNT 5902, 
WNT1886 and ENPP1 4498 




As can be seen in table 1, analyses of the two WNT10b SNPs gave very similar results 
and were associated in common with several bone geometry traits, including: periosteal 
circumference at radius shaft and cortical thickness at tibia shaft. Radius shaft cortical area was 
significantly associated with WNT 5902 only. There were no associations with volumetric BMD 
measures. The discrepancies between family and population data based results could possibly be 
explained by gender differences. As is well known that sex is one of the most important 
confounders for studying bones, in Tobago family data, we included both males and females 
whereas we studies in the population data we exclusively studied men.   
Also in table 1, the last 5 rows, strong associations were observed between ENPP1 
genotypes and volumetric BMD traits, but not bone geometry traits. The presence of two copies 
of “A” allele of ENPP1 4498 was correlated with decreased trabecular and cortical density at 
radius and tibia. The signal between this SNP and cortical density at tibia shaft was confirmed by 
the Tobago population study.  It might be possible that our findings are due to the pure chance if 
you considered about the small sample size for rare homozygotes. However, our preliminary 
results were supported by other two indirect study evidences in Caucasians from Mr. OS data 
(population base, sample size ~ 880 people). First, the same SNP (rs1044498) was shown to be 
specifically correlated with femoral neck integral and cortical BMD, but nothing else (L. Yerges, 
unpublished data); Second, another ENPP1 SNP (rs6916495), which demonstrates high LD with 
ENPP1 4498 (R2=0.75), were found by our colleagues showing association driven by decreased 
femoral shaft BMC but not bone size (L. Yerges, abstract for European calcified tissue society, 
2007).       
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It was very interesting to find out in our association results that for WNT10b SNPs, none 
of the pQCT measured BMD traits come out to be significant in both family and population 
based association study. Very similar, but with reverse pattern, we observed only pQCT 
measured trabecular or cortical density phenotypes, but not bone size traits, were associated with 
SNP ENPP1 4498. We previously concluded (see chapter III) that pQCT measured BMD traits 
shared few common genes with bone size traits; the genetic correlation was low between these 
two categories of bone traits. Our observations that WNT10b is associated with bone geometry 
traits but not volumetric BMD, whereas ENPP1 is associated with volumetric BMD, but not 
bone geometry, is consistent with our previous observation and provides molecular evidence that 
specific genes may affect the variations of BMD and bone size independently.  
6.3.2 Association with Composite Phenotypes from Multivariate Analysis 
Finally, in table 2, we present the association analysis results between composite phenotypes 
derived from raw and residual traits and three SNPs. As we can see here, the empirical P values 
are similar to those nominal ones in most cases. Several interesting patterns were observed. First, 
we observed more significant associations between the ENPP1 SNP genotypes and the 
composite traits compared to the two WNT10b SNPs. This is true for both nominal and empirical 
P-values. The above result is sensible because our composite traits were constructed from 12 
BMD related traits, and not bone geometry traits.  As reported above (table 1), the ENPP1 SNP 
was associated with volumetric BMD traits, whereas, WNT10B SNPs were associated with bone 
size related traits. Second, we reported (in chapter V), that the loadings, the proportion of 
variances, and even the residual heritability are very similar for PCs derived from raw and 
residual underlying traits. Therefore, we would expect similar association results for both types 
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of composite traits. However, from table 2, we found the discrepancy rate is 56% (5 out of 9 
cases). Among 4 of these 5 cases, we observed the signals in PC (raw) but not in PC (residual). 
Thus, based on previous results (Chapter 4), it is possible there are interactions between any of 
our pre-adjusted covariates (age, sex, height and weight) and the SNPs.  
Finally, the association analyses of based on the composite traits are more and stronger 
than those using individual traits.  For example, 6 out of 12 PC traits showed a nominally 
significant result with ENPP1, where as 3 out of 12 original traits gave a nominally significant 
result. Besides, instead of getting more border line nominal P values by raw raws (P values are 
between 0.03-0.06), many of highly significant P values (P≤ 0.01) were observed for composite 
phenotypes. Given the other strengths of multivariate analysis such as reduction of multiple 
testing and ability for exploring the pleiotropy effect, we might recommend the multivariate 
method in our further association analysis in Tobago project.   
Table 30. Nominal P value for association between composite traits and SNPs 





We tested for association between the polymorphisms of three SNPs (two WNT10b SNPs and 
one ENPP1 SNP) and more than thirty different skeletal measurements, which include (areal and 
volumetric) BMD traits and bone size traits. We also reported the association results between the 
same three SNPs and composite phenotypes derived by multivariate analysis from 12 original 
BMD traits.  
We found nominally significant association signals between the two WNT10b SNPs and 
bone size related traits, but none of pQCT measured BMD traits. In contrast, association between 
SNPs in ENPP1 and bone phenotypes were observed exclusively on pQCT measured trabecular 
and cortical BMD, but not bone size. The above results may suggest that there were specific 
genetic determinants affecting the variations of BMD and bone size separately, which agrees 
with the previous conclusions of a low genetic correlation between BMD and bone size related 
traits.  
In addition, we also detected many nominally-significant associations between the SNP 
ENPP1 4498 and BMD derived composite phenotypes, but fewer associations with the two WNT 
SNPs. Because the composite traits were derived from BMD traits, and not bone geometry traits, 
this result is consistent with the individual trait analyses. In addition, because of substantial 
discrepancies of association signals for raw and residual composite traits, we suggest that gene-
environment interactions may be present between the three SNPs genotypes and the bone traits. 
Finally, we believe using the multivariate methods in association analyses in our study may 
benefit our research because we observed more and stronger association signals with composite 
phenotypes than for the original bone traits.  
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7.0  CONCLUSIONS 
As is well-known, populations of African ancestry have greater bone strength and consequently 
lower osteoporotic fracture risk than other ethnic groups, such as Caucasians or Asians. 
However, despite their lower osteoporotic risk, the number of affected blacks is expected to 
increase dramatically throughout the next half century due to increases in longevity and the 
number of older adults at risk. In sharp contrast to our understanding of the etiology and 
prevention of osteoporosis in Caucasians, there is a paucity of information about skeletal health 
in non-white populations, and particularly those of African heritage. As part of this dissertation, I 
investigated the complex genetic and environmental architecture of bone strength-related 
phenotypes in large, extended multigenerational families of Tobago, an African origin 
population.   
Specifically I 
(1) identified environmental covariates that influenced bone strength-related traits and 
determined what proportion of the phenotypic variation was attributable to genetic and 
environmental factors;  
(2) examined the relationship between trabecular and cortical bone density traits: How these 
two types of bone density traits genetically and environmentally correlated to each other; 
(3) confirmed the hypothesis that there is little shared genetic and environmental determinants 
which controlled for the co-variations BMD and bone size traits; 
 135 
(4) tested the possibility in our data if the weight bearing traits and non-weight bearing traits 
were influenced by different sets of unique genes separately; 
(5) explored the application of multivariate analysis for studying bones: using the composite 
phenotypes derived from PCA and FA analysis from both simulation and real data, we 
evaluated the performance of these two methods for uncovering underlying genetic 
components.   
 
Summary of results 
 
First of all, through the cross sectional study, we found Tobago population has similar 
peak total hip and femoral neck areal BMD compared to African American, but higher than 
Caucasians. However, the bone loss rate in the Tobago population is the lowest among all these 
three populations.  Besides, we also observed the gender difference among these bone traits. All 
measures of areal BMD and most of volumetric BMD at radius and tibia (except for cortical 
BMD) are significantly greater in men than in women. We identified several environment 
covariates that explain 12% - 38% of original variation of BMD traits. These significant 
environment factors include but are not limited to age, sex, weight, height, menopause, current 
smoking and drinking alcohol status, parity and diabetes etc. Among them, sex, height and 
weight accounted for the majority (73% to 99%) of the total variation due to these significant 
covariates. On the other hand, the proportion of total variation caused by additive genetic factors 
accounted for as much as or more of the total phenotypic variation than did measured covariates. 
The heritabilities of both areal and volumetric BMD traits mentioned above range from 23%-
52%.  
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 Many of our results support the hypothesis that genetic and environmental influences  on 
trabecular and cortical BMD phenotypes differ. As examples of environmental differences, we 
observed that smoking seems to affect only trabecular traits, whereas parity (ever pregnant ) 
influences only cortical BMD, and current diabetes status has a much stronger impact on 
trabecular versus cortical BMD. In addition, the estimated environmental correlations between 
two trabecular or two cortical traits were high (rhoE equal to 0.48±0.13 to 0.66±0.05, P<0.05), 
but were low between cortical and trabecular traits. This result implies that in addition to 
measured factors such as age, sex, weight and height etc., there exists important unmeasured 
common environmental covariates affecting the shared variance of these two types of traits. The 
first evidence of possible genetic differences between cortical and trabecular bones arises from 
the heritability estimation. We found significantly higher residual heritabilities for trabecular 
than cortical traits at both radius (0.70±0.10 vs. 0.29±0.09) and tibia (0.69±0.10 vs. 0.42±0.10). 
In addition, of the estimated genetic correlations between two trabecular or two cortical sites 
were very high (rhoG equal to 0.82±0.12 to 0.87±0.05, P<0.001), but the rhoGs between 
trabecular and cortical BMD did not differ from 0. Furthermore, multivariate analysis revealed 
that many of composite phenotypes had predominantly higher correlations (higher loadings) for 
either trabecular or cortical BMD traits, but seldom both. The exciting results above may explain 
previous inconsistent findings for DXA measured total BMD phenotypes (i.e. the combinations 
of trabecular and cortical BMD) in which some investigators detected significant covariates or 
candidate genes whereas others did not.         
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Results of this project also indicate that determinants of bone size are independent of 
BMD, which is consistent with results from previous studies in mice. We observed that the 
genetic and environmental correlations between bone size and BMD traits were generally low 
and non-significant. Moreover, genotypes at two WNT10B SNPs were associated with bone size 
related traits, but not BMD traits. In contrast, genotypes at the ENPP1 SNP were associated 
trabecular and cortical BMD traits, but not bone size. This latter results seems to conflict with 
our previous conclusion that trabecular and cortical BMD were largely (but not completely) 
regulated by separate sets of genes. However, the proportion of variance of trabecular and 
cortical traits due to the ENPP1 SNP are between 0.006 and 0.007. Therefore, this minor value 
will not affect any of our above conclusions at all.  
Although investigators report evidence that weight bearing versus non-weight bearing 
bone sites may be influenced by different genetic and environmental factors,  our analyses failed 
to demonstrate any significant differences from results of univariate (significant environment 
correlates and heritabilities), bivariate (genetic and environment correlations) or multivariate 
analysis (loadings of composite traits).  Some possible reasons for the discrepancies between our 
results and the previous studies are as follows: (1) the original   hypothesis is incorrect, (2) the 
Tobago population is different, (3) the smaller sample size in our study was not powerful enough 
to detect a difference. Although we saw no differences for most of BMD measures at the tibia 
and radius, however, for two bone size related traits (tibia length and periosteal circumference), 
the residual heritabilities at the weight bearing skeletal sites were higher than the corresponding 
measures at non-weight bearing skeletal sites.  
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Finally, we addressed several important issues of multivariate analysis by both simulated 
and real family data, although we also realized that there are certain limitations need to be 
acknowledged, such as violation of independence assumption, smaller sample size, limited focus 
only on first composite trait and arbitrary functions in simulation study. First, results of our 
simulation study demonstrated that both PCA and FA behaved qualitatively similar, although FA 
appeared to be better at detecting predominant genetic signals from an underlying trait.  In 
addition, we determined that using residuals in the PCA or FA analyses greatly increased the 
probability that PCs or factors detect common genetic components instead of common 
environmental factors, except if there is statistical interaction between genetic and environmental 
factors.   We also observed no predictable relationship between heritabilities obtained from 
composite phenotypes versus original complex traits, although the composite trait heritability 
generally reflected the genetic characteristics of the detectable underlying components. The latter 
two conclusions (using residual strategy and heritability patterns of composite traits) are 
supported in our analyses of real data assessment. Most importantly, in real data analysis, 
composite phenotypes from multivariate analysis exhibited more and stronger association signals 
with SNP data than those for original bone traits, indicating that they were able to capture the 
underlying genetic signals.            
 
Significance of this dissertation  
 
Results of this study provide the first comprehensive genetic epidemiologic analysis of 
volumetric BMD measured by QCT, and the first analysis of these traits in extended families of 
African descent. The Tobago Family Health Study provided an excellent and unique opportunity 
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to characterize the genetic architecture of several bone strength related traits in a population of 
West African heritage, a group that has been largely under-represented in osteoporosis research. 
Our results will contribute to the better understanding of the genetic and environmental risk 




Results of my project suggest several different avenues for additional research in three general 
categories:  (1) measuring additional bone traits and (2) performing genome wide linkage and 
association (GWL and GLA) studies, and (3) perform gender-specific analyses.  First, as I 
observed in my study, analyzing bone compartments, such as trabecular and cortical bone, 
separately revealed that these two compartments were differentially influenced by both genetic 
and environmental factors.  Information on fancier phenotypes measured by latest advanced 
technology (High Definition QCT, Magnetic Resonance Imaging) might be even better 
surrogates for bone strength and provide greater insights regarding the mechanisms involved in 
regulating bone strength. In addition, obtaining bone measurements by central CT at different 
skeletal sites would enable comparisons between QCT and DXA measured phenotypes, as well 
as allow us to determine whether environmental and genetic factors have systemic or localized 
effects on bone. Second, because of the strong evidence that different genes influence specific 
bone compartments, obtaining genotype data on markers across the genome would enable the 
eventual identification of these genes, and perhaps gene by environment interactions, using 
univariate and multivariate GWL and GWA methods. Last but not the least, we need to keep 
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increasing our sample size to generate higher power, especially for gender specific analysis of 
the different bone compartments. 
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